<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="lgmd2a" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">lgmd2a</book-part-id>
      <title-group>
        <title>Calpainopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Angelini</surname>
            <given-names>Corrado</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="lgmd2a.Td.aff1"/>
          <xref ref-type="aff" rid="lgmd2a.Td.aff2"/>
          <email>corrado.angelini@unipd.it</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fanin</surname>
            <given-names>Marina</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref ref-type="aff" rid="lgmd2a.Td.aff1"/>
          <email>marina.fanin@unipd.it</email>
        </contrib>
      </contrib-group>
      <aff id="lgmd2a.Td.aff1">Department of Neurosciences<break/>University of Padova<break/>Padova, Italy</aff>
      <aff id="lgmd2a.Td.aff2">IRCCS San Camillo Hospital<break/>Venice, Italy</aff>
      <pub-history>
        <date date-type="created">
          <day>10</day>
          <month>5</month>
          <year>2005</year>
        </date>
        <date date-type="updated">
          <day>3</day>
          <month>8</month>
          <year>2017</year>
        </date>
        <date date-type="revised">
          <day>8</day>
          <month>7</month>
          <year>2010</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="caffey" document-type="chapter">Caffey Disease</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="campo-dysp" document-type="chapter">Campomelic Dysplasia</related-object>
      <abstract id="lgmd2a.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Calpainopathy is characterized by symmetric and progressive weakness of proximal limb-girdle muscles. The age at onset of muscle weakness ranges from two to 40 years. The phenotype shows intra- and interfamilial variability ranging from severe to mild.</p>
          <p>Three autosomal recessive calpainopathy phenotypes have been identified based on the distribution of muscle weakness and age at onset:</p>
          <list list-type="bullet">
            <list-item>
              <p>Pelvifemoral limb-girdle muscular dystrophy (LGMD) (Leyden-M&#x000f6;bius LGMD) phenotype, the most frequently observed calpainopathy phenotype, in which muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle, with onset that may occur as early as before age 12 years or as late as after age 30 years</p>
            </list-item>
            <list-item>
              <p>Scapulohumeral LGMD (Erb LGMD) phenotype, usually a milder phenotype with infrequent early onset, in which muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle</p>
            </list-item>
            <list-item>
              <p>HyperCKemia, usually observed in children or young individuals, in which individuals are asymptomatic and have high serum creatine kinase (CK) concentrations</p>
            </list-item>
          </list>
          <p>The autosomal dominant form of calpainopathy shows a variability of clinical phenotype, ranging from almost asymptomatic to wheelchair dependence after age 60 years in few cases with a generally milder phenotype than the recessive form.</p>
          <p>Clinical findings of calpainopathy include the tendency to walk on tiptoe, difficulty in running, scapular winging, waddling gait, and slight hyperlordosis. Other findings include symmetric weakness of proximal more than distal muscles in the limbs, trunk, and periscapular area; laxity of the abdominal muscles; Achilles tendon shortening; scoliosis; and joint contractures. Affected individuals typically do not have cardiac involvement or intellectual disability.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of calpainopathy, which is suggested by clinical findings and elevated serum CK concentration, is established by identification of biallelic pathogenic variants in <italic toggle="yes">CAPN3</italic> (encoding proteolytic enzyme calpain-3) or a dominantly acting heterozygous pathogenic variant for the <italic toggle="yes">CAPN3</italic> 21-bp deletion (c.643_663del21) by molecular genetic testing. If such testing is not available or not conclusive, muscle biopsy with protein immuno-analysis should be used for diagnostic confirmation.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Physical therapy and stretching exercises to promote mobility and prevent contractures; aids such as canes, walkers, orthotics, and wheelchairs to help maintain independence; surgery for foot deformities, scoliosis, and Achilles tendon contractures as needed; respiratory aids to treat chronic respiratory insufficiency in late stages of the disease.</p>
          <p><italic toggle="yes">Surveillance:</italic> Monitoring of muscle strength, joint range of motion, respiratory function, and orthopedic complications.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Strenuous and excessive muscle exercise; obesity and excessive weight loss; physical trauma, bone fractures, and prolonged immobility.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Calpainopathy is typically inherited in an autosomal recessive manner. Less commonly, calpainopathy is inherited in an autosomal dominant manner. In the autosomal recessive form, at conception each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. To date, all individuals diagnosed with autosomal dominant calpainopathy have inherited a pathogenic <italic toggle="yes">CAPN3</italic> variant from a heterozygous parent. Testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the <italic toggle="yes">CAPN3</italic> pathogenic variant(s) in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="lgmd2a.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="lgmd2a.Te" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_lgmd2a.Te_1_1_1_1" valign="middle" align="left" scope="col" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">Calpainopathy: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_lgmd2a.Te_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Pelvifemoral limb-girdle muscular dystrophy (Leyden-M&#x000f6;bius LGMD)</p>
                    </list-item>
                    <list-item>
                      <p>Scapulohumeral limb-girdle muscular dystrophy (Erb LGMD)</p>
                    </list-item>
                    <list-item>
                      <p>HyperCKemia</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="lgmd2a.Nomenclature">Nomenclature</xref>.</p>
            </fn>
            <fn id="lgmd2a.TF.e.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes see <xref ref-type="sec" rid="lgmd2a.Differential_Diagnosis">Differential Diagnosis</xref><italic toggle="yes">.</italic></p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="lgmd2a.Diagnosis">
        <title>Diagnosis</title>
        <p>Calpainopathy is a form of limb-girdle muscular dystrophy (LGMD).</p>
        <sec id="lgmd2a.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Calpainopathy <bold>should be suspected</bold> in individuals with the following clinical findings and test results.</p>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Proximal muscle weakness (pelvic and/or shoulder girdle) with early onset (age &#x0003c;12 years), adult onset, or late onset (age &#x0003e;30 years)</p>
            </list-item>
            <list-item>
              <p>Symmetric atrophy and wasting of proximal limb and trunk muscles; calf hypertrophy is rarely and sometimes only transiently present [<xref ref-type="bibr" rid="lgmd2a.REF.fardeau.1996.295">Fardeau et al 1996</xref>].</p>
            </list-item>
            <list-item>
              <p>Scapular winging, scoliosis, Achilles tendon contracture, and other joint contractures (including hip, knee, elbow, finger, and spine)</p>
            </list-item>
            <list-item>
              <p>Waddling gait; tip-toe walking; difficulty in running, climbing stairs, lifting weights, and getting up from the floor or from a chair</p>
            </list-item>
            <list-item>
              <p>Sparing of facial, ocular, tongue, and neck muscles</p>
            </list-item>
            <list-item>
              <p>Elevated creatine kinase (CK) concentrations, especially in childhood or adolescence, with or without overt muscle symptoms</p>
            </list-item>
            <list-item>
              <p>Absence of cardiomyopathy and intellectual disability</p>
            </list-item>
            <list-item>
              <p>Back pain and myalgia; present in 50% of individuals with dominantly inherited calpainopathy [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>]</p>
            </list-item>
          </list>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Serum creatine kinase (CK) concentration</bold> is always elevated (5-80x normal) from early infancy on, particularly during the active stage of the disease. Serum CK concentration decreases with disease progression, as muscles become more and more atrophic [<xref ref-type="bibr" rid="lgmd2a.REF.urtasun.1998.1735">Urtasun et al 1998</xref>]. In the dominant form of calpainopathy, some individuals presented normal CK levels [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>].</p>
            </list-item>
            <list-item>
              <p>
                <bold>Muscle imaging</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>CT reveals early and striking wasting of muscles predominantly from the posterior compartment of the thighs (but also hip adductors and quadriceps), which is also evident on clinical examination [<xref ref-type="bibr" rid="lgmd2a.REF.fardeau.1996.295">Fardeau et al 1996</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.urtasun.1998.1735">Urtasun et al 1998</xref>], with sparing of the sartorius and gracilis muscles. The difference in distribution of muscle involvement between calpainopathy and other LGMDs (i.e., sarcoglycanopathies and dysferlinopathies) makes muscle imaging analysis an important element in clinical diagnosis [<xref ref-type="bibr" rid="lgmd2a.REF.ten_dam.2012.1716">ten Dam et al 2012</xref>] (see <xref ref-type="sec" rid="lgmd2a.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
                </list-item>
                <list-item>
                  <p>MRI shows this selective muscle involvement and in some cases reveals edema-like changes on STIR sequences [<xref ref-type="bibr" rid="lgmd2a.REF.fischer.2005.538">Fischer et al 2005</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.mercuri.2005.164">Mercuri et al 2005</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.borsato.2006.17">Borsato et al 2006</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.degardin.2010.1219">Degardin et al 2010</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.stramare.2010.585">Stramare et al 2010</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.wattjes.2010.2447">Wattjes et al 2010</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.kana.2014.278">Kana et al 2014</xref>]. Muscle MRI is a useful tool in characterizing the degree of muscle atrophy and in some cases also the severity of the disease [<xref ref-type="bibr" rid="lgmd2a.REF.straub.2012.s42">Straub et al 2012</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.d_azmanera.2015.95">D&#x000ed;az-Manera et al 2015</xref>].</p>
                </list-item>
                <list-item>
                  <p>In the dominant form of calpainopathy, the paraspinal muscles were almost completely lost and replaced by fat [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.prahm.2017.358">Prahm et al 2017</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Electromyogram (EMG)</bold> pattern is typically myopathic (showing small polyphasic potentials), although a normal EMG can also be observed in presymptomatic individuals. Myotonia and spontaneous discharges are not present.</p>
            </list-item>
          </list>
        </sec>
        <sec id="lgmd2a.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of calpainopathy <bold>is established</bold> in a proband by identification of biallelic pathogenic variants in <italic toggle="yes">CAPN3</italic> (encoding proteolytic enzyme calpain-3) or a dominantly acting heterozygous pathogenic variant for the <italic toggle="yes">CAPN3</italic> 21-bp deletion (c.643_663del21) by molecular genetic testing (<xref ref-type="table" rid="lgmd2a.T.molecular_genetic_testing_used">Table 1</xref>). <xref ref-type="sec" rid="lgmd2a.Molecular_Genetic_Testing">Molecular genetic testing</xref> approaches can include use of a <bold>multi-gene panel</bold>, <bold>more comprehensive genomic testing</bold>, and <bold>single-gene testing</bold>.</p>
          <p>For calpainopathy, after the initial clinical workup and exclusion of the more common conditions with overlapping phenotypes, many experts recommend the use of a multi-gene panel or more comprehensive testing as the immediate next step (see <xref ref-type="bibr" rid="lgmd2a.REF.thompson.2016.294">Thompson &#x00026; Straub [2016]</xref>). If the process generates a clear result (biallelic pathogenic variants or a dominantly acting heterozygous pathogenic variant), no further diagnostic laboratory workup is required; if the result is unclear, imaging studies and muscle biopsy with protein immuno-analysis come into play. See <xref ref-type="sec" rid="lgmd2a.Muscle_Biopsy"><bold>Muscle Biopsy</bold></xref>.</p>
          <sec id="lgmd2a.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">CAPN3</italic> and other genes of interest (see <xref ref-type="sec" rid="lgmd2a.Differential_Diagnosis">Differential Diagnosis</xref>) may be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene varies by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of condition at the most reasonable cost while limiting identification of pathogenic variants in genes that do not explain the underlying phenotype. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
            <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation).</p>
            <p>Note: (1) As compared to direct sequencing, more comprehensive genome testing was able to improve the detection rate of calpainopathy [<xref ref-type="bibr" rid="lgmd2a.REF.ghaoui.2015.1424">Ghaoui et al 2015</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.savarese.2016.71">Savarese et al 2016</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.magri.2017.55">Magri et al 2017</xref>]. (2) Many studies have revealed that this type of testing could be a time- and cost-effective method of diagnosing calpainopathy [<xref ref-type="bibr" rid="lgmd2a.REF.bushby.2009.314">Bushby 2009</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.piluso.2011.1584">Piluso et al 2011</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.nigro.2012.196">Nigro &#x00026; Piluso 2012</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.nigro.2014.1">Nigro &#x00026; Savarese 2014</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.ghaoui.2015.1424">Ghaoui et al 2015</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fadaee.2016.277">Fadaee et al 2016</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.kuhn.2016.743">Kuhn et al 2016</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.monies.2016.32">Monies et al 2016</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.seong.2016.484">Seong et al 2016</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fattahi.2017.386">Fattahi et al 2017</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.magri.2017.55">Magri et al 2017</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.reddy.2017.243">Reddy et al 2017</xref>].</p>
            <p>For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            <p><bold>Single-gene testing</bold> may be recommended if a multi-gene panel and/or more comprehensive genomic testing is not available and calpainopathy appears to be a likely diagnosis based on clinical findings. Sequence analysis of <italic toggle="yes">CAPN3</italic> is performed first, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            <p>Targeted analysis for specific pathogenic variants can be performed first in individuals from certain populations/backgrounds. See <xref ref-type="sec" rid="lgmd2a.Molecular_Genetics">Molecular Genetics</xref>.</p>
            <table-wrap id="lgmd2a.T.molecular_genetic_testing_used" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Molecular Genetic Testing Used in Calpainopathy</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_lgmd2a.T.molecular_genetic_testing_used_1_1_1_1" valign="middle" align="left" scope="col" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_lgmd2a.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" scope="col" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_lgmd2a.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" scope="col" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_lgmd2a.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" colspan="1">
                      <italic toggle="yes">CAPN3</italic>
                    </td>
                    <td headers="hd_h_lgmd2a.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_lgmd2a.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">&#x0003e;95%&#x000a0;<sup>4,&#x000a0;5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_lgmd2a.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" colspan="1" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_lgmd2a.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">&#x0003c;5%&#x000a0;<sup>7</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="lgmd2a.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="lgmd2a" object-id="lgmd2a.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="lgmd2a.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="lgmd2a.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="lgmd2a.TF.1.3">
                  <label>3. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="lgmd2a.TF.1.4">
                  <label>4. </label>
                  <p>In individuals showing a severe calpain-3 protein deficiency in muscle biopsy, the probability of identifying pathogenic variants is about 84% [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2004.52">Fanin et al 2004</xref>].</p>
                </fn>
                <fn id="lgmd2a.TF.1.5">
                  <label>5. </label>
                  <p>In approximately 20%-30% of individuals with calpainopathy, only one <italic toggle="yes">CAPN3</italic> pathogenic variant was found, possibly because the second pathogenic variants are located in genomic regions outside the coding exons (e.g., introns or promoter) or are large genomic rearrangements [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2015.163">Fanin &#x00026; Angelini 2015</xref>].</p>
                </fn>
                <fn id="lgmd2a.TF.1.6">
                  <label>6. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
                </fn>
                <fn id="lgmd2a.TF.1.7">
                  <label>7. </label>
                  <p>Large genomic rearrangements involving <italic toggle="yes">CAPN3</italic> have been recognized as causative of calpainopathy [<xref ref-type="bibr" rid="lgmd2a.REF.richard.1999.1524">Richard et al 1999</xref>], including out-of-frame deletion of exons 2-8 [<xref ref-type="bibr" rid="lgmd2a.REF.joncourt.2003.667a">Joncourt et al 2003</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.krahn.2007.582">Krahn et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.todorova.2007.225">Todorova et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.ginjaar.2008.816a">Ginjaar et al 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.nascimbeni.2010.e1658">Nascimbeni et al 2010</xref>], of exons 2-6 [<xref ref-type="bibr" rid="lgmd2a.REF.ginjaar.2008.816a">Ginjaar et al 2008</xref>], or of the entire gene [<xref ref-type="bibr" rid="lgmd2a.REF.jaka.2014.448">Jaka et al 2014</xref>].</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec id="lgmd2a.Muscle_Biopsy">
            <title>Muscle Biopsy</title>
            <p>Muscle biopsy should be used when molecular genetic analysis is not conclusive, or for diagnostic confirmation.</p>
            <p>Note: For this disorder, the results of the specialized studies are much more useful for diagnosis than the routine histopathology of muscle biopsy.</p>
            <p><bold>Histopathology.</bold> A variety of qualitative and quantitative morphologic changes may be observed, irrespective of the age of the individual at the time of biopsy. Wide variability can be observed even among individuals who are homozygous for the same missense variant [<xref ref-type="bibr" rid="lgmd2a.REF.chae.2001.547">Chae et al 2001</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2003.1929">Fanin et al 2003</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p>Most individuals have the typical features of an active dystrophic process (increased fiber size variability, increased fibrosis, regenerating fibers, degenerating and necrotic fibers); others have mild and nonspecific myopathic features: increased central nuclei, fiber splitting, lobulated fibers (misaligned myofibrils that form a lobulated pattern), and type 1 fiber predominance [<xref ref-type="bibr" rid="lgmd2a.REF.vainzof.2003.624">Vainzof et al 2003</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.hermanov_.2006.424">Hermanov&#x000e1; et al 2006</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.keira.2007.513">Keira et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.luo.2011.402">Luo et al 2011</xref>].</p>
              </list-item>
              <list-item>
                <p>The extent of muscle regeneration is less than is typically observed in other LGMDs [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2007a.609">Fanin et al 2007a</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.s_enz.2008.e3750">S&#x000e1;enz et al 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.hauerslev.2012.43">Hauerslev et al 2012</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.rosales.2013.731">Rosales et al 2013</xref>].</p>
              </list-item>
              <list-item>
                <p>Eosinophilic myositis can be an early and transient feature of calpainopathy, which has been reported in individuals with increased CK levels and is not present in muscle from older affected individuals with typical calpainopathy [<xref ref-type="bibr" rid="lgmd2a.REF.brown.2006.875">Brown &#x00026; Amato 2006</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.krahn.2006b.905">Krahn et al 2006b</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.oflazer.2009.261">Oflazer et al 2009</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.krahn.2011.398">Krahn et al 2011</xref>].</p>
              </list-item>
              <list-item>
                <p>There is considerable muscle fiber atrophy, which correlates with the clinical-functional severity of the disease [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2013.762">Fanin et al 2013</xref>] and is significantly higher in affected males than affected females [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2014.179">Fanin et al 2014</xref>].</p>
              </list-item>
              <list-item>
                <p>Muscle biopsies from individuals with dominant calpainopathy show mild myopathic changes (including increased internal nuclei and fiber size variability, occasional necrotic fibers, ring fibers and fibrosis), which however do not reach in severity the level seen in individuals with autosomal recessive calpainopathy [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>].</p>
              </list-item>
            </list>
            <p><bold>Specialized studies: calpain-3 immunoblot analysis.</bold> Calpain-3 immunoblot testing is useful in the diagnosis of calpainopathy [<xref ref-type="bibr" rid="lgmd2a.REF.pollitt.2001.287">Pollitt et al 2001</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2009a.1432">Fanin et al 2009a</xref>] and highly specific when calpain-3 protein is absent or severely reduced [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2004.52">Fanin et al 2004</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.krahn.2006a.444">Krahn et al 2006a</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2009b.598">Fanin et al 2009b</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.luo.2012.723">Luo et al 2012</xref>]. Approximately 80% of individuals with pathogenic variants in <italic toggle="yes">CAPN3</italic> show a complete loss or a severe reduction of calpain-3 protein and 20%-30% have a normal amount of protein (but with loss of protein function) [<xref ref-type="bibr" rid="lgmd2a.REF.talim.2001.692">Talim et al 2001</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2004.52">Fanin et al 2004</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.groen.2007.3237">Groen et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.milic.2007.148">Milic et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2009b.598">Fanin et al 2009b</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.perez.2010.502">Perez et al 2010</xref>].</p>
            <p>Note: The results of calpain-3 immunoblot analysis need to be interpreted with caution, as the analysis is neither completely specific (i.e., it can yield false positive results) nor completely sensitive (i.e., it can yield false negative results). Furthermore, the results must be considered in the context of other muscle proteins [<xref ref-type="bibr" rid="lgmd2a.REF.anderson.1999.1017">Anderson &#x00026; Davison 1999</xref>] and optimal tissue preservation.</p>
            <list list-type="bullet">
              <list-item>
                <p>Lack of specificity:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Calpain-3 protein levels can be partially reduced in other muscular dystrophies, such as <related-object link-type="booklink" source-id="gene" document-id="miyoshi" document-type="chapter">dysferlinopathy</related-object> and <related-object link-type="booklink" source-id="gene" document-id="udd" document-type="chapter">Udd muscular dystrophy</related-object> (titinopathy) [<xref ref-type="bibr" rid="lgmd2a.REF.anderson.2000.553">Anderson et al 2000</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2001.660">Fanin et al 2001</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.haravuori.2001.869">Haravuori et al 2001</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.hackman.2002.492">Hackman et al 2002</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>Although calpain-3 protein is extremely stable in muscle over time, its amount can be partially reduced by the artificial degradation that occurs when muscle tissue is handled or stored under conditions that promote rapid calpain-3 autolysis (e.g., partial thawing and exposure to moisture) [<xref ref-type="bibr" rid="lgmd2a.REF.anderson.1998.1169">Anderson et al 1998</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2003.1929">Fanin et al 2003</xref>].</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>Lack of sensitivity:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>The most important pitfall in calpain-3 protein testing is that it is not completely sensitive in diagnosing LGMD2A [<xref ref-type="bibr" rid="lgmd2a.REF.talim.2001.692">Talim et al 2001</xref>], since approximately 20%-30% of individuals with calpainopathy present a quantitative normal expression of the protein [<xref ref-type="bibr" rid="lgmd2a.REF.groen.2007.3237">Groen et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.milic.2007.148">Milic et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2009b.598">Fanin et al 2009b</xref>], but a loss of function.</p>
                  </list-item>
                  <list-item>
                    <p>When calpain immunoblotting testing shows complete or severe calpain-3 deficiency, the probability that an individual has calpainopathy is very high (84%); the probability progressively decreases as the amount of protein detected increases [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2004.52">Fanin et al 2004</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2009b.598">Fanin et al 2009b</xref>].</p>
                  </list-item>
                </list>
              </list-item>
            </list>
          </sec>
        </sec>
      </sec>
      <sec id="lgmd2a.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="lgmd2a.Clinical_Description">
          <title>Clinical Description</title>
          <p>Calpainopathy is characterized by symmetric and progressive weakness of proximal limb-girdle muscles. The age at onset of muscle weakness depends on phenotype and genotype and ranges from two to 40 years. Early motor milestones are usually normal. Intra- and interfamilial clinical variability ranges from severe to mild [<xref ref-type="bibr" rid="lgmd2a.REF.richard.1999.1524">Richard et al 1999</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2015.163">Fanin &#x00026; Angelini 2015</xref>].</p>
          <p>Three phenotypes of autosomal recessive calpainopathy have been identified based on the distribution of muscle weakness and age at onset:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Pelvifemoral LGMD (Leyden-M&#x000f6;bius LGMD) phenotype,</bold> the most frequently observed calpainopathy phenotype. Muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle. Onset can be early (age &#x0003c;12 years), adult (age 12-30 years), or late (age &#x0003e;30 years). Individuals with early onset and rapid disease course usually have pelvifemoral LGMD.</p>
            </list-item>
            <list-item>
              <p><bold>Scapulohumeral LGMD (Erb LGMD) phenotype.</bold> Muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle. Early onset is infrequent; the disease course is variable, but usually milder than that in the pelvifemoral phenotype.</p>
            </list-item>
          </list>
          <list list-type="bullet">
            <list-item>
              <p><bold>HyperCKemia.</bold> HyperCKemia may be considered a presymptomatic stage of calpainopathy, as it is usually observed in children or in young persons with recessive calpainopathy [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2009a.1432">Fanin et al 2009a</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.kyriakides.2010.767">Kyriakides et al 2010</xref>]. Asymptomatic individuals, who are identified as affected following genetic studies, may develop symptoms of muscle weakness later.</p>
            </list-item>
          </list>
          <p>The autosomal dominant form of calpainopathy shows a variability of clinical phenotype, ranging from almost asymptomatic to wheelchair dependent after age 60 years in a small number of cases [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>]. A prominent feature of such individuals is back pain and myalgia (present in &#x0003e;50% of the heterozygotes for the <italic toggle="yes">CAPN3</italic>
<xref ref-type="table" rid="lgmd2a.T.selected_capn3_pathogenic_varia">c.643_663del21</xref> pathogenic variant). The onset of muscle weakness is on average at age 34 years &#x02013;16 years later than British and Danish individuals with autosomal recessive calpainopathy. Unquestionably, the clinical phenotype of the dominant calpainopathy is generally milder than in recessive calpainopathy.</p>
          <p><bold>The first clinical findings</bold> of calpainopathy are usually:</p>
          <list list-type="bullet">
            <list-item>
              <p>The tendency to walk on tiptoe</p>
            </list-item>
            <list-item>
              <p>Difficulty in running</p>
            </list-item>
            <list-item>
              <p>Scapular winging</p>
            </list-item>
          </list>
          <p>
            <bold>Early stage of the disorder</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The following are frequently observed:</p>
            </list-item>
          </list>
          <list list-type="bullet">
            <list-item>
              <p>Waddling gait and slight hyperlordosis</p>
            </list-item>
            <list-item>
              <p>Symmetric weakness [<xref ref-type="bibr" rid="lgmd2a.REF.matsubara.2007.819">Matsubara et al 2007</xref>] of proximal more than distal muscles in the limbs, trunk, and periscapular area. In particular, the gluteus maximus, thigh adductors, and posterior compartment of the limbs may be severely affected [<xref ref-type="bibr" rid="lgmd2a.REF.fardeau.1996.295">Fardeau et al 1996</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.van_der_kooi.1996.1471">van der Kooi et al 1996</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.din_er.1997.222">Din&#x000e7;er et al 1997</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.topalo_lu.1997.212">Topalo&#x0011f;lu et al 1997</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.urtasun.1998.1735">Urtasun et al 1998</xref>] and facial and neck muscles are usually spared.</p>
            </list-item>
            <list-item>
              <p>Scapular winging</p>
            </list-item>
            <list-item>
              <p>Marked laxity of the abdominal muscles [<xref ref-type="bibr" rid="lgmd2a.REF.bushby.1999.1403">Bushby 1999</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.pollitt.2001.287">Pollitt et al 2001</xref>]</p>
            </list-item>
            <list-item>
              <p>Early Achilles tendon shortening and scoliosis</p>
            </list-item>
          </list>
          <list list-type="bullet">
            <list-item>
              <p>Variable findings include:</p>
            </list-item>
          </list>
          <list list-type="bullet">
            <list-item>
              <p>Muscle pain, exercise intolerance, and excessive lactate production in some individuals similar to that seen in a pseudo-metabolic myopathy [<xref ref-type="bibr" rid="lgmd2a.REF.p_nissonbesnier.1998.1078">P&#x000e9;nisson-Besnier et al 1998</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.pollitt.2001.287">Pollitt et al 2001</xref>];</p>
            </list-item>
            <list-item>
              <p>Eosinophilic myositis, an early and transient feature, with increased CK level; it is not present in older individuals [<xref ref-type="bibr" rid="lgmd2a.REF.brown.2006.875">Brown &#x00026; Amato 2006</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.krahn.2006b.905">Krahn et al 2006b</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.krahn.2011.398">Krahn et al 2011</xref>];</p>
            </list-item>
            <list-item>
              <p>Significant atrophy of the calf muscle or more rarely, calf hypertrophy;</p>
            </list-item>
            <list-item>
              <p>Rhabdomyolysis (and/or myoglobinuria) triggered by physical exercise; occasionally observed in asymptomatic individuals or in individuals with mild muscle involvement [<xref ref-type="bibr" rid="lgmd2a.REF.lahoria.2016.29">Lahoria &#x00026; Milone 2016</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Advanced stage of the disorder</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Commonly observed:</p>
            </list-item>
          </list>
          <list list-type="bullet">
            <list-item>
              <p>The inability to climb stairs, to rise up from a chair, to lift weights, or to get up from the floor</p>
            </list-item>
            <list-item>
              <p>Joint contractures (in the hips, knees, elbows, and fingers)</p>
            </list-item>
          </list>
          <list list-type="bullet">
            <list-item>
              <p>Occasionally observed:</p>
            </list-item>
          </list>
          <list list-type="bullet">
            <list-item>
              <p>Rigid spine [<xref ref-type="bibr" rid="lgmd2a.REF.pollitt.2001.287">Pollitt et al 2001</xref>]</p>
            </list-item>
            <list-item>
              <p>Foot drop [<xref ref-type="bibr" rid="lgmd2a.REF.burke.2010.407">Burke et al 2010</xref>]</p>
            </list-item>
            <list-item>
              <p>Respiratory insufficiency with reduced lung vital capacity to 30%-50% due to deficiency in diaphragmatic function, weakness in thoracic and abdominal muscles, and scoliosis [<xref ref-type="bibr" rid="lgmd2a.REF.fardeau.1996.295">Fardeau et al 1996</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.urtasun.1998.1735">Urtasun et al 1998</xref>]. Compromised respiratory function was observed in 11% of individuals showing forced vital capacity lower than 50% [<xref ref-type="bibr" rid="lgmd2a.REF.richard.2016.248">Richard et al 2016</xref>]. Some of those with severe respiratory insufficiency required the use of respiratory aids [<xref ref-type="bibr" rid="lgmd2a.REF.moriyoshimura.2017.465">Mori-Yoshimura et al 2017</xref>].</p>
            </list-item>
          </list>
          <list list-type="bullet">
            <list-item>
              <p>Uncommon: Cardiomyopathy. In most individuals cardiac symptoms that precede cardiac morbidity (including chest pain, lower limb oedema, palpitations) are not present, and cardiac abnormalities may be identified by echocardiography or electrocardiography. A systematic evaluation of heart involvement in a group of affected individuals using cardiovascular magnetic resonance showed the lack of cardiac involvement in this disorder, even in individuals with advanced age and greater disorder severity [<xref ref-type="bibr" rid="lgmd2a.REF.quick.2015.661">Quick et al 2015</xref>]. A few individuals have presented with non-life-threatening cardiac abnormalities [<xref ref-type="bibr" rid="lgmd2a.REF.richard.2016.248">Richard et al 2016</xref>], atrial fibrillation, or variably impaired left ventricular function [<xref ref-type="bibr" rid="lgmd2a.REF.groen.2007.3237">Groen et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.okere.2013.e12">Okere et al 2013</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.moriyoshimura.2017.465">Mori-Yoshimura et al 2017</xref>].</p>
            </list-item>
          </list>
          <p>Note: Neither intellectual disability nor macroglossia is associated with this disorder.</p>
          <p><bold>Progression and variability.</bold> The asymptomatic stage may be relatively long in some affected individuals, especially in females. In some individuals with calpainopathy, the onset of symptoms or the worsening of symptoms may be influenced by environmental factors, such as infectious disease, strenuous physical exercise, drug treatment, a traumatic event, or pregnancy [<xref ref-type="bibr" rid="lgmd2a.REF.s_enz.2005.732">S&#x000e1;enz et al 2005</xref>].</p>
          <p>The disease is invariably progressive and loss of ambulation occurs approximately ten to 30 years after the onset of symptoms (between ages 10 and 48 years) [<xref ref-type="bibr" rid="lgmd2a.REF.richard.1999.1524">Richard et al 1999</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.zatz.2003.532">Zatz et al 2003</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.s_enz.2005.732">S&#x000e1;enz et al 2005</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.angelini.2010.41">Angelini et al 2010</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.gallardo.2011.97">Gallardo et al 2011</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.richard.2016.248">Richard et al 2016</xref>]. In general, loss of independent ambulation occurs earlier in individuals with infantile onset of the disease [<xref ref-type="bibr" rid="lgmd2a.REF.gallardo.2011.97">Gallardo et al 2011</xref>].</p>
          <p>A more rapid progression of the disease was observed in males than in females [<xref ref-type="bibr" rid="lgmd2a.REF.de_paula.2002.825">de Paula et al 2002</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.zatz.2003.532">Zatz et al 2003</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.piluso.2005.686">Piluso et al 2005</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.richard.2016.248">Richard et al 2016</xref>]. In a natural history clinical study of affected individuals, a higher proportion of women were still walking as compared to men (72% versus 48% in men) [<xref ref-type="bibr" rid="lgmd2a.REF.richard.2016.248">Richard et al 2016</xref>]. Males are more susceptible to muscle fiber atrophy than females and more affected by the consequent muscle weakness and clinical disability [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2014.179">Fanin et al 2014</xref>].</p>
          <p>Intrafamilial variability in the clinical phenotype has been reported: in sibs with the same pathogenic variant the age at onset and the clinical course can vary considerably [<xref ref-type="bibr" rid="lgmd2a.REF.schessl.2008.54">Schessl et al 2008</xref>], suggesting the influence of genetic background and environmental factors in determining the course of the disease.</p>
        </sec>
        <sec id="lgmd2a.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>There is no consistent genotype-phenotype correlation in calpainopathy, although null homozygous variants are generally associated with a severe phenotype and absent calpain-3 protein in muscle [<xref ref-type="bibr" rid="lgmd2a.REF.richard.1999.1524">Richard et al 1999</xref>].</p>
          <p>A single heterozygous in-frame <xref ref-type="table" rid="lgmd2a.T.selected_capn3_pathogenic_varia">c.643_663del21</xref> pathogenic variant in <italic toggle="yes">CAPN3</italic> results in a dominantly inherited form of calpainopathy [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>].</p>
        </sec>
        <sec id="lgmd2a.Penetrance">
          <title>Penetrance</title>
          <p>Nearly full penetrance is observed in adulthood. Some individuals remain asymptomatic until adulthood. Serum CK concentration is usually increased until the advanced stage of the disease.</p>
        </sec>
        <sec id="lgmd2a.Nomenclature">
          <title>Nomenclature</title>
          <p>Calpainopathy was originally called LGMD2A because it was the first form of autosomal recessive LGMD to be mapped [<xref ref-type="bibr" rid="lgmd2a.REF.beckmann.1991.141">Beckmann et al 1991</xref>], but in recently revised nomenclature the designation LGMDR1 has been proposed (LGMDR refers to genetic types of LGMD showing autosomal recessive inheritance).</p>
          <p><xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al [2016]</xref> proposed that the recently characterized autosomal dominant form of calpainopathy associated with the c.643_663del21 pathogenic variant be designated LGMD1I in the current nomenclature (LGMD1 refers to genetic types of LGMD showing dominant inheritance), and designated LGMDD3 in revised nomenclature (LGMDD refers to genetic types of LGMD showing autosomal dominant inheritance).</p>
          <p>As both recessive and dominant forms are associated with calpain-3 abnormality, calpainopathy is the preferred term for this disorder.</p>
        </sec>
        <sec id="lgmd2a.Prevalence">
          <title>Prevalence</title>
          <p>Calpainopathy is considered the most common form of LGMD [<xref ref-type="bibr" rid="lgmd2a.REF.bushby.2003">Bushby &#x00026; Beckmann 2003</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.guglieri.2008.258">Guglieri et al 2008</xref>], representing approximately 30% of LGMD cases, depending on the geographic region [<xref ref-type="bibr" rid="lgmd2a.REF.chou.1999.1015">Chou et al 1999</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.zatz.2000.511">Zatz et al 2000</xref>]. Estimates based on molecular data indicate that the frequency of calpainopathy ranges from 6%-8% of all LGMD in Australia, Korea, and Germany [<xref ref-type="bibr" rid="lgmd2a.REF.hanisch.2007.157">Hanisch et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.shin.2007.463">Shin et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.lo.2008.34">Lo et al 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.ghaoui.2015.1424">Ghaoui et al 2015</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.seong.2016.484">Seong et al 2016</xref>], to 4%-12% in the USA [<xref ref-type="bibr" rid="lgmd2a.REF.chou.1999.1015">Chou et al 1999</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.moore.2006.995">Moore et al 2006</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.reddy.2017.243">Reddy et al 2017</xref>], 13% in Denmark [<xref ref-type="bibr" rid="lgmd2a.REF.duno.2008.935">Duno et al 2008</xref>], 16% in Saudi Arabia [<xref ref-type="bibr" rid="lgmd2a.REF.monies.2016.32">Monies et al 2016</xref>], 17%-18% in Mexico and northern China [<xref ref-type="bibr" rid="lgmd2a.REF.g_mezd_az.2012.338">G&#x000f3;mez-D&#x000ed;az et al 2012</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.mahmood.2013.1907">Mahmood et al 2013</xref>], 21% in the Netherlands [<xref ref-type="bibr" rid="lgmd2a.REF.van_der_kooi.2007.2125">van der Kooi et al 2007</xref>], 21%-26% in Japan and Lithuania [<xref ref-type="bibr" rid="lgmd2a.REF.kawai.1998.1493">Kawai et al 1998</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.minami.1999.31">Minami et al 1999</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.luo.2011.402">Luo et al 2011</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.inashkina.2016.200">Inashkina et al 2016</xref>], 24% in Iran [<xref ref-type="bibr" rid="lgmd2a.REF.fattahi.2017.386">Fattahi et al 2017</xref>], 25%-35% in Italy, Germany, and northern England [<xref ref-type="bibr" rid="lgmd2a.REF.piluso.2005.686">Piluso et al 2005</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.guglieri.2008.258">Guglieri et al 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2009a.1432">Fanin et al 2009a</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.norwood.2009.3175">Norwood et al 2009</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.kuhn.2016.743">Kuhn et al 2016</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.magri.2017.55">Magri et al 2017</xref>], 32% in Brazil [<xref ref-type="bibr" rid="lgmd2a.REF.zatz.2000.511">Zatz et al 2000</xref>], 33% in Czech Republic [<xref ref-type="bibr" rid="lgmd2a.REF.stehl_kov_.2014.154">Stehl&#x000ed;kov&#x000e1; et al 2014</xref>], 40%-50% in France, Turkey, Spain, India, Slovenia, and Bulgaria [<xref ref-type="bibr" rid="lgmd2a.REF.din_er.1997.222">Din&#x000e7;er et al 1997</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.richard.1997.1128">Richard et al 1997</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.meznaricpetrusa.2002.73a">Meznaric-Petrusa et al 2002</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.georgieva.2005.399">Georgieva et al 2005</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.s_enz.2005.732">S&#x000e1;enz et al 2005</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.balci.2006.293">Balci et al 2006</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.todorova.2007.225">Todorova et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.pathak.2010.549">Pathak et al 2010</xref>], and 80% in Basque country, Russia, and Poland [<xref ref-type="bibr" rid="lgmd2a.REF.urtasun.1998.1735">Urtasun et al 1998</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.pogoda.2000.295">Pogoda et al 2000</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.dadali.2010.79">Dadali et al 2010</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.dorobek.2015.637">Dorobek et al 2015</xref>].</p>
          <p>A genetic epidemiologic study in northeastern Italy estimated that calpainopathy has a prevalence of approximately 1:100,000 inhabitants (corresponding to a carrier frequency of ~1:160) [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2005.218">Fanin et al 2005</xref>]. Another study in southern Italy estimated the prevalence of calpainopathy at 1:42,700 inhabitants (corresponding to a carrier frequency of ~1:103) [<xref ref-type="bibr" rid="lgmd2a.REF.piluso.2005.686">Piluso et al 2005</xref>].</p>
          <p>Higher prevalence rates have been calculated in small and genetically isolated communities; the prevalence of the disease has been estimated at 48 per million in the Reunion Island [<xref ref-type="bibr" rid="lgmd2a.REF.fardeau.1996.295">Fardeau et al 1996</xref>], 69 per million in Basque country [<xref ref-type="bibr" rid="lgmd2a.REF.urtasun.1998.1735">Urtasun et al 1998</xref>], 1900 per million in the M&#x000f2;cheni community in the Alps [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2012.601">Fanin et al 2012</xref>], 4300 per million in the Tlaxcala village in central Mexico (with a carrier frequency of 1:11) [<xref ref-type="bibr" rid="lgmd2a.REF.pantojamelendez.2017.e0170280">Pantoja-Melendez et al 2017</xref>], and 13000 per million in the Amish population of Indiana [<xref ref-type="bibr" rid="lgmd2a.REF.young.1992.1370">Young et al 1992</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.richard.1995.27">Richard et al 1995</xref>].</p>
          <p>Three general population screening studies of the most common <italic toggle="yes">CAPN3</italic> pathogenic variant (<xref ref-type="table" rid="lgmd2a.T.selected_capn3_pathogenic_varia">c.550delA</xref>) in Lithuania, Croatia, and Poland resulted in the identification of healthy carriers, corresponding to estimated carrier frequencies of 1:175, 1:133, and 1:124 respectively [<xref ref-type="bibr" rid="lgmd2a.REF.cankiklain.2004.152">Canki-Klain et al 2004</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.dorobek.2015.637">Dorobek et al 2015</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.inashkina.2016.200">Inashkina et al 2016</xref>].</p>
        </sec>
      </sec>
      <sec id="lgmd2a.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are associated with pathogenic variants in <italic toggle="yes">CAPN3</italic>.</p>
      </sec>
      <sec id="lgmd2a.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Other forms of autosomal recessive limb-girdle muscular dystrophy</bold> (LGMD2 or LGMDR in revised nomenclature; see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS253600?sort=phenotypeMimNumber">OMIM Phenotypic Series: Muscular dystrophy, limb-girdle, autosomal recessive</ext-link>) cannot be distinguished from calpainopathy on clinical grounds, although calpainopathy generally has a later onset and is relatively mild, particularly by comparison with sarcoglycanopathies [<xref ref-type="bibr" rid="lgmd2a.REF.nigro.2014.1">Nigro &#x00026; Savarese 2014</xref>]. Multi-gene panels are increasingly used to identify pathogenic variants and confirm a diagnosis of a specific form of LGMD. If this approach is not available, immunoblot analysis of muscle biopsy for candidate proteins (sarcoglycans, dysferlin, telethonin, titin) can help establish the correct diagnosis (see <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">Limb-Girdle Muscular Dystrophy Overview</related-object>).</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="fsh" document-type="chapter"><bold>Facioscapulohumeral muscular dystrophy</bold></related-object>
<bold>(FSHD)</bold> shares some clinical and laboratory features with Erb LGMD (one of the calpainopathy phenotypes) [<xref ref-type="bibr" rid="lgmd2a.REF.leidenroth.2012.999">Leidenroth et al 2012</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.sacconi.2012.41">Sacconi et al 2012</xref>] in which muscle weakness with onset in the shoulder girdle, scapular winging, elevated serum CK concentration, and nonspecific myopathic changes on muscle biopsy can be seen. However, facial muscle weakness and asymmetric scapular muscle involvement, which can be observed in FSHD, are uncommon in calpainopathy. Inheritance is autosomal dominant; although some controversy remains, FSHD is likely caused by inappropriate expression of the double homeobox-containing gene <italic toggle="yes">DUX4</italic> in muscle cells.</p>
        <p>In a few cases, both a contracted D4Z4 fragment (<italic toggle="yes">DUX4</italic>) and a heterozygous pathogenic variant in <italic toggle="yes">CAPN3</italic> have been identified in association with limb-girdle and facioscapulohumeral muscular dystrophy-like phenotype [<xref ref-type="bibr" rid="lgmd2a.REF.pastorello.2012.230">Pastorello et al 2012</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.simeoni.2015.292">Simeoni et al 2015</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="dbmd" document-type="chapter"><bold>Dystrophinopathy</bold></related-object><bold>.</bold> The dystrophinopathies include a spectrum of muscle disease caused by pathogenic variants in <italic toggle="yes">DMD</italic>, which encodes the protein dystrophin. Dystrophinopathy was diagnosed in about 17% of individuals with a clinical diagnosis of LGMD (31% of males and 13% of females) [<xref ref-type="bibr" rid="lgmd2a.REF.arikawa.1991.1491">Arikawa et al 1991</xref>], emphasizing the clinical overlap between LGMD and dystrophinopathy. The correct diagnosis can be established in most affected individuals by molecular genetic testing of <italic toggle="yes">DMD</italic>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="dbmd" document-type="chapter"><bold>Becker muscular dystrophy</bold></related-object>
<bold>(BMD),</bold> muscle disease at the mild end of the dystrophinopathy spectrum, should be considered in males with clinical and laboratory features that are in common with calpainopathy: onset of weakness in the lower girdle muscles in adolescence or adulthood and elevated serum CK concentrations. An X-linked pattern of inheritance or the presence of heart involvement (mainly dilated cardiomyopathy), distinguish BMD from calpainopathy [<xref ref-type="bibr" rid="lgmd2a.REF.shaboodien.2015.152">Shaboodien et al 2015</xref>].</p>
        <p><bold>Metabolic myopathy.</bold> Calpainopathy has been reported in individuals with asthenia, myalgias, exercise intolerance, lower-limb proximal muscle weakness, and excessive lactate production after aerobic exercise [<xref ref-type="bibr" rid="lgmd2a.REF.p_nissonbesnier.1998.1078">P&#x000e9;nisson-Besnier et al 1998</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.pollitt.2001.287">Pollitt et al 2001</xref>]. In metabolic myopathies muscle weakness can be either distal (e.g., glycogenosis type 3) or proximal (e.g., glycogenosis type 2) and may be transitory (e.g., CPT-2 deficiency) or permanent (e.g., glycogenosis type 2 and glycogenosis type 5). Metabolic myopathies are also different from calpainopathy because of vacuolar muscle biopsy histopathologic features (e.g., glycogen storage).</p>
        <p>The association between rhabdomyolysis and LGMD is less recognized than the association between rhabdomyolysis and metabolic myopathies (i.e. CPT2 deficiency); this often leads to misdiagnosis or delayed diagnosis. Some individuals with calpainopathy presented rhabdomyolytic episodes, mild muscle weakness, and persistent elevation of CK levels even at distance from a myoglobinuric episode (whereas in metabolic myopathies CK levels between myoglobinuric episodes is usually normal) [<xref ref-type="bibr" rid="lgmd2a.REF.lahoria.2016.29">Lahoria &#x00026; Milone 2016</xref>].</p>
        <p><bold>Myopathy with contractures.</bold> The phenotype of calpainopathy may include muscle weakness with severe tendon contractures [<xref ref-type="bibr" rid="lgmd2a.REF.pollitt.2001.287">Pollitt et al 2001</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.gallardo.2011.97">Gallardo et al 2011</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.richard.2016.248">Richard et al 2016</xref>], raising the possibility of <related-object link-type="booklink" source-id="gene" document-id="edmd" document-type="chapter">Emery-Dreifuss muscular dystrophy</related-object>.</p>
      </sec>
      <sec id="lgmd2a.Management">
        <title>Management</title>
        <sec id="lgmd2a.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with calpainopathy, the following evaluations are recommended if they have not already been completed:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete physical evaluation including the grading of muscle strength in single upper, lower, proximal, and distal muscles and the analysis of several functional performances</p>
            </list-item>
            <list-item>
              <p>Orthopedic examination when gait is severely impaired</p>
            </list-item>
            <list-item>
              <p>When walking ability is compromised, an evaluation for physical therapy and orthoses, especially in later stages of the disease</p>
            </list-item>
            <list-item>
              <p>Baseline pulmonary function testing (including forced vital capacity measurement)</p>
            </list-item>
            <list-item>
              <p>Baseline cardiac evaluation including echocardiogram</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="lgmd2a.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Appropriate management, tailored to each individual, can improve quality of life and prolong survival. The general approach is based on the typical progression and complications of individuals with LGMD as described by <xref ref-type="bibr" rid="lgmd2a.REF.mcdonald.1995.s117">McDonald et al [1995]</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.bushby.1999.1403">Bushby [1999]</xref>, and <xref ref-type="bibr" rid="lgmd2a.REF.norwood.2007.1305">Norwood et al [2007]</xref>, and revised by the Committee of the American Academy of Neurology [<xref ref-type="bibr" rid="lgmd2a.REF.narayanaswami.2014.1453">Narayanaswami et al 2014</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>A passive physical therapy program [<xref ref-type="bibr" rid="lgmd2a.REF.oygard.2011.20">Oygard et al 2011</xref>] and stretching exercises should be instituted early after diagnosis to promote mobility, prolong walking, and slow the disease progression, in particular by maintaining joint flexibility. Individuals usually benefit from strengthening and gentle [<xref ref-type="bibr" rid="lgmd2a.REF.sveen.2013.163">Sveen et al 2013</xref>], low-impact aerobic exercise (swimming, stationary bicycling) with a supervised sub-maximal effort, which improves cardiovascular performance, increases muscle efficiency, and lessens muscle fatigue. Although there are no specific reports on supportive care, physical and occupational therapies are important [<xref ref-type="bibr" rid="lgmd2a.REF.eagle.2002.975">Eagle 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>Avoidance of prolonged immobility is recommended.</p>
            </list-item>
            <list-item>
              <p>Technical aids can also compensate for the loss of certain motor abilities; canes, walkers, orthotics, and wheelchairs enable individuals to regain independence. The use of knee-ankle-foot orthoses at bedtime is recommended to prevent contractures. Scoliosis occurs mainly after wheelchair dependence and attention should be paid to seating [<xref ref-type="bibr" rid="lgmd2a.REF.norwood.2007.1305">Norwood et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>Surgical intervention may be required for correction of orthopedic complications including foot deformities, scoliosis, and Achilles tendon contractures. Occasionally, scapular fixation may be required for particularly problematic scapular winging.</p>
            </list-item>
            <list-item>
              <p>In the late stage of the disease, chronic respiratory insufficiency may occur and the use of respiratory aids may be indicated to prolong survival [<xref ref-type="bibr" rid="lgmd2a.REF.pollitt.2001.287">Pollitt et al 2001</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.norwood.2007.1305">Norwood et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.d_angelo.2011.54">D&#x02019;Angelo et al 2011</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.richard.2016.248">Richard et al 2016</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.moriyoshimura.2017.465">Mori-Yoshimura et al 2017</xref>].</p>
              <list list-type="bullet">
                <list-item>
                  <p>Individuals should be monitored for signs of nocturnal hypoventilation (sleep disturbances, early morning headache, daytime drowsiness).</p>
                </list-item>
                <list-item>
                  <p>Overnight pulse oxymetry is recommended if forced vital capacity is lower than 60% and the demonstration of nocturnal hypoventilation should lead to noninvasive nocturnal ventilation [<xref ref-type="bibr" rid="lgmd2a.REF.norwood.2007.1305">Norwood et al 2007</xref>].</p>
                </list-item>
                <list-item>
                  <p>Intervention in the form of nocturnal ventilator assistance for respiratory failure (by noninvasive positive pressure ventilation, NIV, by nasal masks) may be life saving in severely affected individuals [<xref ref-type="bibr" rid="lgmd2a.REF.dirik.2001.235">Dirik et al 2001</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.hashiguchi.2014.1097">Hashiguchi et al 2014</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.moriyoshimura.2017.465">Mori-Yoshimura et al 2017</xref>].</p>
                </list-item>
                <list-item>
                  <p>Wheelchair-bound individuals may also develop weak cough efforts, placing them at risk of atelectasia, pneumonia, progressive mismatch, and respiratory failure.</p>
                </list-item>
                <list-item>
                  <p>Annual influenza vaccination and prompt treatment for chest and respiratory infections should be eventually addressed using a mechanical in-ex-sufflator [<xref ref-type="bibr" rid="lgmd2a.REF.moriyoshimura.2017.465">Mori-Yoshimura et al 2017</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Social and emotional support help to improve the quality of life, to maximize a sense of social involvement and productivity, and to reduce the sense of social isolation [<xref ref-type="bibr" rid="lgmd2a.REF.eggers.1998.4">Eggers &#x00026; Zatz 1998</xref>].</p>
            </list-item>
            <list-item>
              <p>Clinicians should anticipate and facilitate decision-making for affected individuals and their families as the disease progresses, including decisions regarding loss of mobility and need of assistance with activities of daily living, medical complications, and end-of-life care [<xref ref-type="bibr" rid="lgmd2a.REF.narayanaswami.2014.1453">Narayanaswami et al 2014</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="lgmd2a.Prevention_of_Secondary_Manifesta">
          <title>Prevention of Secondary Manifestations</title>
          <p>There are a number of measures that decrease disease manifestations in a symptomatic individual: control of weight gain, prevention of joint contractures by means of physical therapy and stretching exercises, and in the advanced stage, control of respiratory insufficiency. Physical therapy and stretching exercises can help to slow disease progression; therefore, a physical therapy program should be instituted early after diagnosis.</p>
        </sec>
        <sec id="lgmd2a.Surveillance">
          <title>Surveillance</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Annual monitoring of muscle strength, joint range of motion, and respiratory function:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Monitoring for orthopedic complications, such as foot deformities, scoliosis, and Achilles tendon contractures</p>
                </list-item>
                <list-item>
                  <p>Referral for pulmonary evaluation (eventually including pulmonary function tests) when there are complaints of excessive daytime somnolence, non-restorative sleep, early morning headache [<xref ref-type="bibr" rid="lgmd2a.REF.narayanaswami.2014.1453">Narayanaswami et al 2014</xref>]. Measurement of forced vital capacity should be made in sitting and supine position.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Examination of cardiac function in the advanced stage of disease (although it is not frequently compromised) [<xref ref-type="bibr" rid="lgmd2a.REF.dirik.2001.235">Dirik et al 2001</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.okere.2013.e12">Okere et al 2013</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="lgmd2a.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Strenuous and eccentric muscle exercise should be discouraged as it exacerbates muscle necrosis and could precipitate the onset of weakness or accelerate muscle wasting. Although individuals with minimal muscle weakness and functional limitation may be able to perform strenuous exercise, in some cases this may result in rhabdomyolysis and myoglobinuria [<xref ref-type="bibr" rid="lgmd2a.REF.lahoria.2016.29">Lahoria &#x00026; Milone 2016</xref>] which may lead to severe complications such as acute renal failure and compartment syndrome.</p>
          <p>Body weight should be controlled to avoid obesity as well as excessive weight loss (atrophy of muscles can be accelerated by loss of muscle proteins).</p>
          <p>Physical trauma, bone fractures, and prolonged immobility can induce disuse atrophy and thus should be avoided.</p>
          <p>Although no association of the disease with malignant hyperthermia is reported, the use of succinylcholine and halogenated anesthetic agents should be avoided when possible (see <related-object link-type="booklink" source-id="gene" document-id="mhs" document-type="chapter">Malignant Hyperthermia Susceptibility</related-object>).</p>
          <p>While the specific mechanism whereby cholesterol-lowering agents (e.g., statins) may produce muscle damage causing pain or weakness is unknown, such drugs should be avoided when possible.</p>
        </sec>
        <sec id="lgmd2a.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an affected individual by molecular genetic testing of the <italic toggle="yes">CAPN3</italic> pathogenic variant in the family in order to identify as early as possible those who would benefit from initiation of evaluation and subsequent surveillance. With the associated intrafamilial phenotype variability, the possibility of calpainopathy should not be excluded in sibs on the basis of absence of symptoms alone.</p>
          <p>See <xref ref-type="sec" rid="lgmd2a.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="lgmd2a.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Women with calpainopathy do not have impaired uterine smooth muscle strength or function and typically have uncomplicated pregnancies. A higher incidence of abnormal fetal presentation was reported in wheelchair-bound individuals with LGMD [<xref ref-type="bibr" rid="lgmd2a.REF.awater.2012.153">Awater et al 2012</xref>]. Epidural blockade can be difficult in those with severe spine deformities and appropriate general anaesthesia may be necessary. About half of persons with LGMD reported deterioration of clinical symptoms in pregnancy [<xref ref-type="bibr" rid="lgmd2a.REF.awater.2012.153">Awater et al 2012</xref>].</p>
        </sec>
        <sec id="lgmd2a.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="lgmd2a.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="lgmd2a.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Calpainopathy is typically inherited in an autosomal recessive manner. Less commonly, calpainopathy is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="lgmd2a.Risk_to_Family_Members__Autosomal">
          <title>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">CAPN3</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The offspring of an affected individual are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">CAPN3</italic>.</p>
            </list-item>
            <list-item>
              <p>In populations with a high rate of consanguinity, the reproductive partner of an affected individual may be a carrier, in which case the risk to the offspring of being affected is 50%.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of a <italic toggle="yes">CAPN3</italic> pathogenic variant.</p>
          <p>
            <bold>Carrier (heterozygote) detection</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Carrier testing for at-risk family members requires prior identification of the <italic toggle="yes">CAPN3</italic> pathogenic variants in the family.</p>
            </list-item>
            <list-item>
              <p>If the reproductive partner of an affected individual (or known carrier) belongs to the same genetic isolate and is therefore at an increased risk of being a carrier of an <italic toggle="yes">CAPN3</italic> pathogenic variant (see <xref ref-type="sec" rid="lgmd2a.Prevalence">Prevalence</xref>), carrier testing may be requested and is generally done by sequence analysis.</p>
            </list-item>
          </list>
        </sec>
        <sec id="lgmd2a.Risk_to_Family_Members__Autosomal_1">
          <title>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>To date, all individuals diagnosed with autosomal dominant calpainopathy inherited a <italic toggle="yes">CAPN3</italic> pathogenic variant from a heterozygous parent. Clinical variability has been reported within families [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>] and a heterozygous parent may or may not have clinical features of calpainopathy.</p>
            </list-item>
            <list-item>
              <p>To date, <italic toggle="yes">de novo</italic> occurrence of the autosomal dominant form of calpainopathy has not been reported.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing is recommended for the parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> variant in the proband or germline mosaicism in a parent (though theoretically possible, no instances of germline mosaicism have been reported).</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with autosomal dominant calpainopathy may appear to be negative because of early death of the parent before the onset of symptoms, late onset of the disease in the affected parent (see <xref ref-type="sec" rid="lgmd2a.Penetrance">Penetrance</xref>), or subclinical manifestations of calpainopathy in a heterozygous parent [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>]. Therefore, an apparently negative family history cannot be confirmed unless molecular genetic testing has been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents:</p>
          <list list-type="bullet">
            <list-item>
              <p>If a parent of the proband is affected and/or is known to be heterozygous for the <italic toggle="yes">CAPN3</italic> pathogenic variant, the risk to sibs is 50%. Intrafamilial clinical variability ranging from asymptomatic to wheelchair dependence has been observed [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>].</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">CAPN3</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental germline mosaicism.</p>
            </list-item>
            <list-item>
              <p>If both parents are clinically unaffected but have not been tested for the <italic toggle="yes">CAPN3</italic> pathogenic variant, the sibs of a proband are still at increased risk for calpainopathy because of the possibility of reduced penetrance in a parent or the theoretic possibility of parental germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with autosomal dominant calpainopathy has a 50% chance of inheriting the <italic toggle="yes">CAPN3</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent has the <italic toggle="yes">CAPN3</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="lgmd2a.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="lgmd2a.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers (e.g., asymptomatic relatives of known affected individuals).</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="lgmd2a.Prenatal_Testing_and_Preimplantat">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CAPN3</italic> pathogenic variant(s) have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible. Prenatal diagnosis for calpainopathy has been requested from heterozygous couples, who previously had an affected child [<xref ref-type="bibr" rid="lgmd2a.REF.restagno.1996.173">Restagno et al 1996</xref>].</p>
        </sec>
      </sec>
      <sec id="lgmd2a.Resources">
        <title>Resources</title>
      </sec>
      <sec id="lgmd2a.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> The longest <italic toggle="yes">CAPN3</italic> transcript variant comprises 24 exons and covers a genomic region of 50 kb. It is expressed as a 3.5-kb transcript (2466 coding nucleotides). <italic toggle="yes">CAPN3</italic> encodes a number of alternatively spliced transcripts [<xref ref-type="bibr" rid="lgmd2a.REF.herasse.1999.4047">Herasse et al 1999</xref>]. Alternate promoters and alternative splicing result in multiple transcript variants encoding different isoforms and some variants are ubiquitously expressed [<xref ref-type="bibr" rid="lgmd2a.REF.de_tullio.2003.689">De Tullio et al 2003</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.kawabata.2003.623">Kawabata et al 2003</xref>].</p>
        <p>Muscle tissue expresses only one isoform (the full-length transcript), whereas leukocytes express four different transcripts (produced by alternative splicing of exons 6,15,16), all of which lack exon 15. Since peripheral blood instead of muscle tissue has increasingly been used to obtain mRNA for cDNA sequencing, the results of the two analyses could be discordant in some cases [<xref ref-type="bibr" rid="lgmd2a.REF.bl_zquez.2008.173">Bl&#x000e1;zquez et al 2008</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="lgmd2a" object-id="lgmd2a.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> According to the Leiden Muscular Dystrophy Mutation Database, more than 490 pathogenic variants have been reported; they are distributed throughout <italic toggle="yes">CAPN3</italic> [<xref ref-type="bibr" rid="lgmd2a.REF.anderson.1998.1169">Anderson et al 1998</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.de_paula.2002.825">de Paula et al 2002</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.zatz.2003.532">Zatz et al 2003</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2004.52">Fanin et al 2004</xref>].</p>
        <p>Most pathogenic variants are single-nucleotide changes. Approximately 70% of abnormal alleles are missense variants; the remaining are a variety of loss-of-function variants (small deletions or insertions causing frameshift and premature stop codon, nonsense, and splice site variants) [<xref ref-type="bibr" rid="lgmd2a.REF.richard.1999.1524">Richard et al 1999</xref>].</p>
        <p>About 25% of pathogenic variants in <italic toggle="yes">CAPN3</italic> are located at exon-intron boundaries and cause aberrant splicing [<xref ref-type="bibr" rid="lgmd2a.REF.krahn.2007.582">Krahn et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.bl_zquez.2008.173">Bl&#x000e1;zquez et al 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.nascimbeni.2010.e1658">Nascimbeni et al 2010</xref>].</p>
        <p>Many deep intronic pathogenetic variants that disrupt the correct splicing can be overlooked by sequencing of genomic DNA [<xref ref-type="bibr" rid="lgmd2a.REF.krahn.2007.582">Krahn et al 2007</xref>]; their identification may require the sequencing of cDNA obtained from muscle or blood tissues [<xref ref-type="bibr" rid="lgmd2a.REF.krahn.2006a.444">Krahn et al 2006a</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.bl_zquez.2008.173">Bl&#x000e1;zquez et al 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.nascimbeni.2010.e1658">Nascimbeni et al 2010</xref>].</p>
        <p>Deep intronic variants causing a pseudo-exonization of an intronic sequence have been reported [<xref ref-type="bibr" rid="lgmd2a.REF.bl_zquez.2008.173">Bl&#x000e1;zquez et al 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.bl_zquez.2013.1387">Bl&#x000e1;zquez et al 2013</xref>], as well as large exon deletions, the most frequent of which is an out-of-frame 31,012-bp deletion of exons 2-8 (c.309+4469_c.1116-1204del) [<xref ref-type="bibr" rid="lgmd2a.REF.richard.1999.1524">Richard et al 1999</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.joncourt.2003.667a">Joncourt et al 2003</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.krahn.2007.582">Krahn et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.todorova.2007.225">Todorova et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.ginjaar.2008.816a">Ginjaar et al 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.nascimbeni.2010.e1658">Nascimbeni et al 2010</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.piluso.2011.1584">Piluso et al 2011</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.bartoli.2012.99">Bartoli et al 2012</xref>]. Since this deletion recurs in calpainopathy in individuals from different ethnic backgrounds, it is probably due to independent mutation events [<xref ref-type="bibr" rid="lgmd2a.REF.todorova.2007.225">Todorova et al 2007</xref>].</p>
        <p>Genomic rearrangements of Alu elements [<xref ref-type="bibr" rid="lgmd2a.REF.salem.2012.92">Salem et al 2012</xref>], the entire <italic toggle="yes">CAPN3</italic> gene deletion [<xref ref-type="bibr" rid="lgmd2a.REF.jaka.2014.448">Jaka et al 2014</xref>], and synonymous codon variants [<xref ref-type="bibr" rid="lgmd2a.REF.richard.1995.259">Richard &#x00026; Beckmann 1995</xref>] have been occasionally reported.</p>
        <p>A single heterozygous in-frame c.643_663del21 pathogenic variant in <italic toggle="yes">CAPN3</italic> results in a dominantly inherited form of calpainopathy [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>]. Of note, this variant has been identified in compound heterozygosity with other pathogenic variants in <italic toggle="yes">CAPN3</italic>, including c.2362_2363delinsTCATCT, c.550delA, p.Ala45Thr, and p.Asp419Gly [<xref ref-type="bibr" rid="lgmd2a.REF.richard.1997.1128">Richard et al 1997</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.groen.2007.3237">Groen et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.s_enz.2017.e7">S&#x000e1;enz &#x00026; L&#x000f3;pez de Munain 2017</xref>].</p>
        <p>Many pathogenic variants have been observed repeatedly in different populations; the c.550delA pathogenic variant is the most common allele (accounting for up to 75% of abnormal alleles) among individuals from different European countries [<xref ref-type="bibr" rid="lgmd2a.REF.richard.1999.1524">Richard et al 1999</xref>].</p>
        <p>Pathogenic variants that recur in the following populations are most likely the result of a founder effect followed by genetic isolation; especially in small populations, the accumulation of specific pathogenic variants (also called &#x0201c;private mutations&#x0201d;) may be explained by consanguinity associated with historical, demographic, or cultural/religious factors:</p>
        <list list-type="bullet">
          <list-item>
            <p>Reunion Island in the Indian Ocean (c.946-1G&#x0003e;A) [<xref ref-type="bibr" rid="lgmd2a.REF.fardeau.1996.295">Fardeau et al 1996</xref>]</p>
          </list-item>
          <list-item>
            <p>Old Order Amish community in northern Indiana, USA (p.Arg769Gln) [<xref ref-type="bibr" rid="lgmd2a.REF.young.1992.1370">Young et al 1992</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.richard.1995.27">Richard et al 1995</xref>]</p>
          </list-item>
          <list-item>
            <p>Russia, Croatia, Turkey, Czech Republic, Bulgaria, Germany, Italy, Poland (c.550delA) [<xref ref-type="bibr" rid="lgmd2a.REF.din_er.1997.222">Din&#x000e7;er et al 1997</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.pogoda.2000.295">Pogoda et al 2000</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.cankiklain.2004.152">Canki-Klain et al 2004</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.chrob_kov_.2004.659">Chrob&#x000e1;kov&#x000e1; et al 2004</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2005.218">Fanin et al 2005</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.milic.2005.657">Milic &#x00026; Canki-Klain 2005</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.balci.2006.293">Balci et al 2006</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.hanisch.2007.157">Hanisch et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.todorova.2007.225">Todorova et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.stehl_kov_.2014.154">Stehl&#x000ed;kov&#x000e1; et al 2014</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.dorobek.2015.637">Dorobek et al 2015</xref>]. This pathogenic variant may have originated in the eastern Mediterranean region [<xref ref-type="bibr" rid="lgmd2a.REF.hermanov_.2006.424">Hermanov&#x000e1; et al 2006</xref>].</p>
          </list-item>
          <list-item>
            <p>Guipuzcoa province in the Basque country of Spain, and in Brazil (c.2362_2363delAGinsTCATCT) [<xref ref-type="bibr" rid="lgmd2a.REF.urtasun.1998.1735">Urtasun et al 1998</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.de_paula.2002.825">de Paula et al 2002</xref>]</p>
          </list-item>
          <list-item>
            <p>Japan (c.1795_1796insA) [<xref ref-type="bibr" rid="lgmd2a.REF.kawai.1998.1493">Kawai et al 1998</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.chae.2001.547">Chae et al 2001</xref>]</p>
          </list-item>
          <list-item>
            <p>Chioggia village in the Venetian lagoon of Italy (p.Arg490Gln) [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2005.218">Fanin et al 2005</xref>]</p>
          </list-item>
          <list-item>
            <p>M&#x000f2;cheni community in the Fersina River valley in the Italian Alps (c.1193+6T&#x0003e;A) [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2012.601">Fanin et al 2012</xref>]</p>
          </list-item>
          <list-item>
            <p>Agarwal community in northern India (p.Asp780His, c.2099-1G&#x0003e;T, c.2051-1G&#x0003e;T) [<xref ref-type="bibr" rid="lgmd2a.REF.ankala.2013.931">Ankala et al 2013</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.khadilkar.2016.108">Khadilkar et al 2016</xref>]</p>
          </list-item>
          <list-item>
            <p>Northern European countries including UK, Norway, Sweden, Denmark (dominantly inherited c.643_663del21) [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>]</p>
          </list-item>
          <list-item>
            <p>Tlaxcala village in central Mexico (p.Ala116Asp) [<xref ref-type="bibr" rid="lgmd2a.REF.pantojamelendez.2017.e0170280">Pantoja-Melendez et al 2017</xref>]</p>
          </list-item>
        </list>
        <p>For more information, see <related-object source-id="gene" document-id="lgmd2a" object-id="lgmd2a.molgen.TA">Table A</related-object>.</p>
        <table-wrap id="lgmd2a.T.selected_capn3_pathogenic_varia" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Selected <italic toggle="yes">CAPN3</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="col" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" scope="col" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_3" valign="middle" align="left" scope="col" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1" colspan="1">c.133G&#x0003e;A</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">p.Ala45Thr</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_3" rowspan="14" valign="middle" align="left" style="background-color:rgb(255,255,255)" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000070.2">NM_000070.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000061.1">NP_000061.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1" colspan="1">c.347C&#x0003e;A&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">p.Ala116Asp</td>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1" colspan="1">c.550delA</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">p.Thr184ArgfsTer33</td>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1" colspan="1">c.643_663del21</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">p.Ser215_Gly221del</td>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1" colspan="1">c.946-1G&#x0003e;A<break/>(IVS6-1G&#x0003e;A)</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">--</td>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="col" rowspan="1" colspan="1">c.1193+6T&#x0003e;A</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1" colspan="1">c.1265A&#x0003e;G</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">p.Asp419Gly</td>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1" colspan="1">c.1466G&#x0003e;A</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">p.Arg489Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1" colspan="1">c.1795_1796insA</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">p.Thr599AsnfsTer30</td>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="col" rowspan="1" colspan="1">c.2051-1G&#x0003e;T</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="col" rowspan="1" colspan="1">c.2099-1G&#x0003e;T</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1" colspan="1">c.2306G&#x0003e;A</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">p.Arg769Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1" colspan="1">c.2338G&#x0003e;C</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">p.Asp780His</td>
              </tr>
              <tr>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_1" valign="middle" align="left" style="background-color:rgb(255,255,255)" scope="row" rowspan="1" colspan="1">c.2362_2363delAGinsTCATCT<break/>(2362AG&#x0003e;TCATCT)</td>
                <td headers="hd_h_lgmd2a.T.selected_capn3_pathogenic_varia_1_1_1_2" valign="middle" align="left" style="background-color:rgb(255,255,255)" rowspan="1" colspan="1">p.Arg788SerfsTer13</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. GeneReviews staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: GeneReviews follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="lgmd2a.TF.2.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
            <fn id="lgmd2a.TF.2.2">
              <label>2. </label>
              <p>This variant was reported as c.348C&#x0003e;A; however, based on the sequencing trace in <xref ref-type="bibr" rid="lgmd2a.REF.pantojamelendez.2017.e0170280">Pantoja-Melendez et al [2017]</xref> the correct naming of this variant is c.347C&#x0003e;A.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> Calpain-3 is an enzymatic protein of approximately 94 kd molecular weight (also called p94) composed of 821 amino acids. It is the muscle-specific member of a family of Ca<sup>++</sup>-activated neutral proteases, which cleave proteins into short polypeptides. Calpain-3 is a multidomain protein with three exclusive sequence inserts (NS, IS1, IS2) [<xref ref-type="bibr" rid="lgmd2a.REF.ono.1998.17073">Ono et al 1998</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>Domain I. Regulatory role</p>
          </list-item>
          <list-item>
            <p>Domain II. Proteolytic module</p>
          </list-item>
          <list-item>
            <p>Domain III. C2-like domain</p>
          </list-item>
          <list-item>
            <p>Domain IV. Binds Ca<sup>++</sup> ions [<xref ref-type="bibr" rid="lgmd2a.REF.ono.1998.17073">Ono et al 1998</xref>].</p>
          </list-item>
          <list-item>
            <p>Sequence NS. Unknown function [<xref ref-type="bibr" rid="lgmd2a.REF.sorimachi.2001.653">Sorimachi &#x00026; Suzuki 2001</xref>]</p>
          </list-item>
          <list-item>
            <p>Sequence IS1. Three autocatalytic sites [<xref ref-type="bibr" rid="lgmd2a.REF.kinbara.1998.415">Kinbara et al 1998</xref>]</p>
          </list-item>
          <list-item>
            <p>Sequence IS2. Contains a nuclear translocation signal, suggesting that calpain-3 may have a function in the nucleus, processing transcription factors.</p>
          </list-item>
        </list>
        <p>Calpain-3 is expressed predominantly in skeletal muscle. Upon stimulation, calpain-3 both activates and inactivates itself rapidly through autocatalysis. In the sarcomeres, calpain-3 directly binds to titin [<xref ref-type="bibr" rid="lgmd2a.REF.keira.2003.659">Keira et al 2003</xref>] and changes its localization from the M-lines to the NA2 regions as the sarcomeres extend. Calpain-3 is thought to process proteins involved in signaling pathways, transcription factors, calcium transport, and cytoskeletal proteins as part of a process called sarcomere remodeling, in which the synthesis of novel proteins is balanced by the degradation of misfolded proteins [<xref ref-type="bibr" rid="lgmd2a.REF.baghdiguian.1999.503">Baghdiguian et al 1999</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.baghdiguian.2001.254">Baghdiguian et al 2001</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.kramerova.2005.2125">Kramerova et al 2005</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.duguez.2006.3427">Duguez et al 2006</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.kramerova.2007.128">Kramerova et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.beckmann.2008.913">Beckmann &#x00026; Spencer 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.benayoun.2008.1521">Benayoun et al 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.kramerova.2008.3271">Kramerova et al 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.s_enz.2008.e3750">S&#x000e1;enz et al 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2009c.383">Fanin et al 2009c</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.ono.2010.22986">Ono et al 2010</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.ermolova.2011.3331">Ermolova et al 2011</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The majority of <italic toggle="yes">CAPN3</italic> pathogenic variants are loss-of-function variants and result in recessive disease. Most individuals with calpainopathy have complete or partial calpain-3 protein deficiency on muscle biopsy. In 10%-30% of individuals with calpainopathy, muscle biopsy shows a normal amount of protein [<xref ref-type="bibr" rid="lgmd2a.REF.talim.2001.692">Talim et al 2001</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.de_paula.2002.825">de Paula et al 2002</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2004.52">Fanin et al 2004</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.groen.2007.3237">Groen et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.milic.2007.148">Milic et al 2007</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2009b.598">Fanin et al 2009b</xref>] even though calpain-3 may have lost its autocatalytic activity and may be functionally inactive [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2003.1929">Fanin et al 2003</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.fanin.2007b.38">Fanin et al 2007b</xref>].</p>
        <p>The mobility of calpain-3 between the sarcomeric M-lines and the cytosol may have a key role in physical stress, and it is compromised in calpainopathy when its protease activity has been lost. An impairment of calpain proteolytic activity results in sarcomere remodeling by promoting ubiquitin-mediated degradation of sarcomeric proteins [<xref ref-type="bibr" rid="lgmd2a.REF.duguez.2006.3427">Duguez et al 2006</xref>]. This degradation process may depend on ubiquitous calpains in the initial stage, and on the UPS in the later stages [<xref ref-type="bibr" rid="lgmd2a.REF.kramerova.2005.2125">Kramerova et al 2005</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.beckmann.2008.913">Beckmann &#x00026; Spencer 2008</xref>, <xref ref-type="bibr" rid="lgmd2a.REF.rajakumar.2013.2009">Rajakumar et al 2013</xref>]. Impaired sarcomere remodeling would also affect myoblast fusion and repair, as well as the regenerative capacity of muscle in calpainopathy. The activation of the muscle atrophy process appears to depend mainly on the induction of the ubiquitin-proteasome system [<xref ref-type="bibr" rid="lgmd2a.REF.fanin.2013.762">Fanin et al 2013</xref>].</p>
        <p>The mechanism by which <italic toggle="yes">CAPN3</italic> pathogenic variants result in a dominant disease has been proposed to be a dominant-negative effect [<xref ref-type="bibr" rid="lgmd2a.REF.vissing.2016.2154">Vissing et al 2016</xref>]. Since the active calpain-3 is a homodimer, the aberrant protein could polymerize with the wild type protein and render the complex inactive.</p>
      </sec>
      <sec id="lgmd2a.References">
        <title>References</title>
        <sec id="lgmd2a.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="lgmd2a.Literature_Cited.reflist0">
            <ref id="lgmd2a.REF.anderson.1998.1169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davison</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tome</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lasa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colomer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A.</article-title>
                <source>Am J Pathol</source>
                <volume>153</volume>
                <fpage>1169</fpage>
                <lpage>79</lpage>
                <pub-id pub-id-type="pmid">9777948</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.anderson.2000.553">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrison</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pogue</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vafiadaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollitt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davison</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahjneh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wrogemann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertorini</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bashir</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies).</article-title>
                <source>Neuromusc Disord</source>
                <volume>10</volume>
                <fpage>553</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11053681</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.anderson.1999.1017">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>LVB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davison</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Multiplex western blotting system for the analysis of muscular dystrophy proteins.</article-title>
                <source>Am J Pathol</source>
                <volume>154</volume>
                <fpage>1017</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">10233840</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.angelini.2010.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardetto</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borsato</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Padoan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasca</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B).</article-title>
                <source>Neurol Res</source>
                <volume>32</volume>
                <fpage>41</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20092694</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.ankala.2013.931">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ankala</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohn</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dastur</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaitonde</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khadilkar</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hegde</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Ancestral founder mutations in calpain-3 in the Indian Agarwal community: historical, clinical, and molecular perspective.</article-title>
                <source>Muscle Nerve</source>
                <volume>47</volume>
                <fpage>931</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23666804</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.arikawa.1991.1491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arikawa</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaido</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugita</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arahata</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>The frequency of patients with dystrophin abnormalities in a limb-girdle patient population.</article-title>
                <source>Neurology</source>
                <volume>41</volume>
                <fpage>1491</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">1842672</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.awater.2012.153">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Awater</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Sch&#x000f6;neborn</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients.</article-title>
                <source>Eur J Obstet Gynecol Reprod Biol</source>
                <volume>162</volume>
                <fpage>153</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22459654</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.baghdiguian.1999.503">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baghdiguian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pons</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Astier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourg</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hay</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chemaly</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halaby</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loiselet</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangeat</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefranc</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A.</article-title>
                <source>Nat Med</source>
                <volume>5</volume>
                <fpage>503</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">10229226</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.baghdiguian.2001.254">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baghdiguian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coopman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangeat</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefranc</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaB alpha/NF-kappaB survival pathway in skeletal muscle.</article-title>
                <source>J Mol Med</source>
                <volume>79</volume>
                <fpage>254</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">11485017</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.balci.2006.293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balci</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aurino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haliloglu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erdem</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akcoren</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caglar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topalo&#x0011f;lu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Din&#x000e7;er</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Calpain-3 mutations in Turkey.</article-title>
                <source>Eur J Pediatr</source>
                <volume>165</volume>
                <fpage>293</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16411092</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.bartoli.2012.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bartoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Negre</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wein</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourgeois</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pecheux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krahn</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Validation of comparative genomic hybridization arrays for the detection of genomic rearrangements of the calpain-3 and dysferlin genes.</article-title>
                <source>Clin Genet</source>
                <volume>81</volume>
                <fpage>99</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">22150418</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.beckmann.1991.141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hillaire</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broux</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bois</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cann</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cottingham</surname>
                    <given-names>RW</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Feingold</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feingold</surname>
                    <given-names>J</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>1991</year>
                <article-title>A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage.</article-title>
                <source>C R Acad Sci III</source>
                <volume>312</volume>
                <fpage>141</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1901754</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.beckmann.2008.913">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spencer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance.</article-title>
                <source>Neuromusc Disord</source>
                <volume>18</volume>
                <fpage>913</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">18974005</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.benayoun.2008.1521">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Benayoun</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baghdiguian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lajmanovich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniele</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gicquel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourg</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raynaud</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquier</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefranc</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>NF-kB-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A.</article-title>
                <source>FASEB J</source>
                <volume>22</volume>
                <fpage>1521</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18073330</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.bl_zquez.2013.1387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bl&#x000e1;zquez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aiastui</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goicoechea</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martins de Araujo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avril</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valc&#x000e1;rcel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fortes</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs.</article-title>
                <source>Hum Mutat</source>
                <volume>34</volume>
                <fpage>1387</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">23864287</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.bl_zquez.2008.173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bl&#x000e1;zquez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azpitarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goicoechea</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otaegui</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutierrez-Rivas</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis.</article-title>
                <source>Neurogenetics</source>
                <volume>9</volume>
                <fpage>173</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">18563459</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.borsato.2006.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Borsato</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Padoan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stramare</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Limb-girdle muscular dystrophies type 2A and 2B: clinical and radiological aspects.</article-title>
                <source>Basic Appl Myol</source>
                <volume>16</volume>
                <fpage>17</fpage>
                <lpage>25</lpage>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.brown.2006.875">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Amato</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Calpainopathy and eosinophilic myositis.</article-title>
                <source>Ann Neurol</source>
                <volume>59</volume>
                <fpage>875</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16718709</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.burke.2010.407">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hillier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sampson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bridges</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barresi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammans</surname>
                    <given-names>SR</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Calpainopathy presenting as foot drop in a 41 year old.</article-title>
                <source>Neuromusc Disord</source>
                <volume>20</volume>
                <fpage>407</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">20580976</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.bushby.2009.314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Diagnosis and management of the limb girdle muscular dystrophies.</article-title>
                <source>Pract Neurol</source>
                <volume>9</volume>
                <fpage>314</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">19923111</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.bushby.1999.1403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Making sense of the limb-girdle muscular dystrophies.</article-title>
                <source>Brain</source>
                <volume>122</volume>
                <fpage>1403</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">10430828</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.bushby.2003">
              <mixed-citation publication-type="confproc">Bushby KM, Beckmann JS (2003) The 105th ENMC sponsored workshop: pathogenesis in the non-sarcoglycan limb-girdle muscular dystrophies, Naarden, April 12-14, 2002. Neuromusc Disord 13:80-90</mixed-citation>
            </ref>
            <ref id="lgmd2a.REF.cankiklain.2004.152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Canki-Klain</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milic</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kovac</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trlaja</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grgicevic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zurak</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leturcq</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piluso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feingold</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Prevalence of the 550delA mutation in calpainopathy (LGMD 2A) in Croatia.</article-title>
                <source>Am J Med Genet A</source>
                <volume>125A</volume>
                <fpage>152</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14981715</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.chae.2001.547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chae</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy.</article-title>
                <source>Neuromusc Disord</source>
                <volume>11</volume>
                <fpage>547</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">11525884</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.chou.1999.1015">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chou</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daentl</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greco</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hausmanowa-Petrusewicz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fidzianska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>EP</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population.</article-title>
                <source>Neurology</source>
                <volume>52</volume>
                <fpage>1015</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">10102422</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.chrob_kov_.2004.659">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chrob&#x000e1;kov&#x000e1;</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermanov&#x000e1;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kroupov&#x000e1;</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vondr&#x000e1;cek</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mar&#x000ed;kov&#x000e1;</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazanec</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000e1;mecn&#x000ed;k</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Havlov&#x000e1;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fajkusov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.</article-title>
                <source>Neuromusc Disord</source>
                <volume>14</volume>
                <fpage>659</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">15351423</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.dadali.2010.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dadali</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shagina</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryzhkova</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudenskaia</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fedotov</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poliakov</surname>
                    <given-names>AV</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Clinical-genetic characteristics of limb girdle-muscular dystrophy type 2A.</article-title>
                <source>Zh Nevrol Psikhiatr Im S S Korsakova</source>
                <volume>110</volume>
                <fpage>79</fpage>
                <lpage>83</lpage>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.d_angelo.2011.54">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>D&#x02019;Angelo</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romei</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lo Mauro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gandossini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turconi</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedotti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aliverti</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Respiratory pattern in an adult population of dystrophic patients.</article-title>
                <source>J Neurol Sci</source>
                <volume>306</volume>
                <fpage>54</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">21529845</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.degardin.2010.1219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Degardin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morillon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacour</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotten</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermersch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stojkovic</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Morphologic imaging in muscular dystrophies and inflammatory myopathies.</article-title>
                <source>Skeletal Radiol</source>
                <volume>39</volume>
                <fpage>1219</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">20449587</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.de_paula.2002.825">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Paula</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vainzof</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passos-Bueno</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de C&#x000e1;ssia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavanello</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matioli</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zatz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Clinical variability in calpainopathy: what makes the difference?</article-title>
                <source>Eur J Hum Genet</source>
                <volume>10</volume>
                <fpage>825</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">12461690</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.de_tullio.2003.689">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Tullio</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stifanese</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salamino</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pontremoli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melloni</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Characterization of a new p94-like calpain form in human lymphocytes.</article-title>
                <source>Biochem J</source>
                <volume>375</volume>
                <fpage>689</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">12882647</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.d_azmanera.2015.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>D&#x000ed;az-Manera</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Llauger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Muscle MRI in muscular dystrophies.</article-title>
                <source>Acta Myol</source>
                <volume>34</volume>
                <fpage>95</fpage>
                <lpage>108</lpage>
                <pub-id pub-id-type="pmid">27199536</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.din_er.1997.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Din&#x000e7;er</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leturcq</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccolo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yalnizoglu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Toma</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ak&#x000e7;&#x000f6;ren</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broux</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deburgrave</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenguier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roudaut</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeanpierre</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topalo&#x0011f;lu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey.</article-title>
                <source>Ann Neurol</source>
                <volume>42</volume>
                <fpage>222</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9266733</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.dirik.2001.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dirik</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aydin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurul</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahin</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Limb girdle muscular dystrophy type 2A presenting with cardiac arrest.</article-title>
                <source>Pediatr Neurol</source>
                <volume>24</volume>
                <fpage>235</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11301229</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.dorobek.2015.637">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dorobek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryniewicz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabzinska</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fidzianska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Styczynska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hausmanowa-Petrusewicz</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>The frequency of c.550delA mutation of the CAPN3 gene in the Polish LGMD2A population.</article-title>
                <source>Genet Test Mol Biomarkers</source>
                <volume>19</volume>
                <fpage>637</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">26484845</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.duguez.2006.3427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Duguez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Calpain 3: a key regulator of the sarcomere?</article-title>
                <source>FEBS J</source>
                <volume>273</volume>
                <fpage>3427</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">16884488</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.duno.2008.935">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Duno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sveen</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>cDNA analyses of CAPN3 enhance mutation detection and reveal a low prevalence of LGMD2A patients in Denmark.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>16</volume>
                <fpage>935</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">18337726</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.eagle.2002.975">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eagle</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Report on the muscular dystrophy campaign workshop: exercise in neuromuscular diseases. Newcastle, January 2002.</article-title>
                <source>Neuromusc Disord</source>
                <volume>12</volume>
                <fpage>975</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">12467755</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.eggers.1998.4">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eggers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zatz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Social adjustment in adult males affected with progressive muscular dystrophy.</article-title>
                <source>Am J Med Genet</source>
                <volume>81</volume>
                <fpage>4</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">9514580</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.ermolova.2011.3331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ermolova</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kudryashova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiFranco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vergara</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramerova</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spencer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Pathogenity of some limb girdle muscular dystrophy mutations can result from reduced anchorage to myofibrils and altered stability of calpain 3.</article-title>
                <source>Hum Mol Genet</source>
                <volume>20</volume>
                <fpage>3331</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">21624972</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fadaee.2016.277">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fadaee</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kariminejad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fattahi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nafissi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reza Godarzi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beheshtian</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vazehan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reza Akbari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahrizi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Najmabadi</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>report of limb girdle muscular dystrophy type 2A in six Iranian patients, one with a novel deletion in CAPN3 gene.</article-title>
                <source>Neuromusc Disord</source>
                <volume>26</volume>
                <fpage>277</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">27020652</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2015.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: the yield and the pitfalls.</article-title>
                <source>Muscle Nerve</source>
                <volume>52</volume>
                <fpage>163</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">25900067</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2012.601">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benedicenti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fritegotto</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterle</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanzial</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cristofoletti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castellan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>An intronic mutation causes severe LGMD2A in a large inbred family belonging to a genetic isolate in the Alps.</article-title>
                <source>Clin Genet</source>
                <volume>82</volume>
                <fpage>601</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">22486197</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2004.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fulizio</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinazzi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piluso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ventriglia</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruzza</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siciliano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trevisan</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Molecular diagnosis in LGMD2A: mutation analysis or protein testing?</article-title>
                <source>Hum Mutat</source>
                <volume>24</volume>
                <fpage>52</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">15221789</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2007a.609">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardetto</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasca</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinazzi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Padoan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2007a</year>
                <article-title>Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2A.</article-title>
                <source>J Med Genet</source>
                <volume>44</volume>
                <fpage>609</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">17526799</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2007b.38">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2007b</year>
                <article-title>Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of CAPN3 gene mutations.</article-title>
                <source>J Med Genet</source>
                <volume>44</volume>
                <fpage>38</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">16971480</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2014.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Gender difference in limb-girdle muscular dystrophy: a muscle fiber morphometric study in 101 patients.</article-title>
                <source>Clin Neuropathol</source>
                <volume>33</volume>
                <fpage>179</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">24618072</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2013.762">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Muscle atrophy in limb girdle muscular dystrophy 2A: a morphometric and molecular study.</article-title>
                <source>Neuropathol Appl Neurobiol</source>
                <volume>39</volume>
                <fpage>762</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">23414389</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2009a.1432">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aurino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasca</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pegoraro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2009a</year>
                <article-title>Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes.</article-title>
                <source>Neurology</source>
                <volume>72</volume>
                <fpage>1432</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19380703</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2005.218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fulizio</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The frequency of limb girdle muscular dystrophy 2A in northeastern Italy.</article-title>
                <source>Neuromusc Disord</source>
                <volume>15</volume>
                <fpage>218</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">15725583</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2003.1929">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fulizio</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trevisan</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meznaric-Petrusa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression.</article-title>
                <source>Am J Pathol</source>
                <volume>163</volume>
                <fpage>1929</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">14578192</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2009b.598">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasca</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2009b</year>
                <article-title>How to tackle the diagnosis of limb-girdle muscular dystrophy 2A.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>17</volume>
                <fpage>598</fpage>
                <lpage>603</lpage>
                <pub-id pub-id-type="pmid">18854869</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2001.660">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pegoraro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuda-Asada</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy.</article-title>
                <source>Neurology</source>
                <volume>56</volume>
                <fpage>660</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11245721</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fanin.2009c.383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasca</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2009c</year>
                <article-title>Sarcolemmal neuronal nitric oxide synthase defect in limb girdle muscular dystrophy: an adverse modulating factor in the disease course?</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>68</volume>
                <fpage>383</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">19287313</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fardeau.1996.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hillaire</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feingold</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feingold</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignard</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Ubeda</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tome</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion Island.</article-title>
                <source>Brain</source>
                <volume>119</volume>
                <fpage>295</fpage>
                <lpage>308</lpage>
                <pub-id pub-id-type="pmid">8624690</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fattahi.2017.386">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fattahi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalhor</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fadaee</surname>
                    <given-names>M</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2017</year>
                <article-title>Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population.</article-title>
                <source>Clin Genet</source>
                <volume>91</volume>
                <fpage>386</fpage>
                <lpage>402</lpage>
                <pub-id pub-id-type="pmid">27234031</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.fischer.2005.538">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kesper</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aurino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubisch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilhelm</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urbach</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;der</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs.</article-title>
                <source>J Neurol</source>
                <volume>252</volume>
                <fpage>538</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">15726252</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.gallardo.2011.97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Limb-girdle muscular dystrophy 2A.</article-title>
                <source>Handb Clin Neurol</source>
                <volume>101</volume>
                <fpage>97</fpage>
                <lpage>110</lpage>
                <pub-id pub-id-type="pmid">21496626</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.georgieva.2005.399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Georgieva</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Todorova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremensky</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mines</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plageras</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>550delA mutation in the calpain 3 (CAPN3) gene: DMD/BMD, SMA, or LGMD2A clinically misdiagnosed cases.</article-title>
                <source>Am J Med Genet</source>
                <volume>136A</volume>
                <fpage>399</fpage>
                <lpage>400</lpage>
                <pub-id pub-id-type="pmid">16001438</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.ghaoui.2015.1424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ghaoui</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corbett</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reddel</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Needham</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waddell</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Grady</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaur</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ong</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sue</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>North</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacArthur</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>NF</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Use of whole-exome sequencing for diagnosis of limb-girdle muscular dystrophy. Outcomes and lessons learned.</article-title>
                <source>JAMA Neurol</source>
                <volume>72</volume>
                <fpage>1424</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">26436962</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.ginjaar.2008.816a">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ginjaar</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuit</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frankhuizen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Kooi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doorn</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sival</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>MLPA analysis of the CAPN3 gene detects large deletions in LGMD2A patients.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>18</volume>
                <fpage>816A</fpage>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.g_mezd_az.2012.338">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>G&#x000f3;mez-D&#x000ed;az</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosas-Vargas</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roque-Ramirez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meza-Espinoza</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruano-Calderon</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez-Valverde</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Escalante-Bautista</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Escobar-Cedillo</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Chapul</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargas-Canas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez-Hernandez</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahena-Martinez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luna-Angulo</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canto</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coral-Vazquez</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Immunodetection analysis of muscular dystrophies in Mexico.</article-title>
                <source>Muscle Nerve</source>
                <volume>45</volume>
                <fpage>338</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">22334167</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.groen.2007.3237">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Groen</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charlton</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barresi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eagle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koref</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>KMD</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>3237</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">18055493</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.guglieri.2008.258">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guglieri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Angelo</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morandi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodolico</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cagliani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mora</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fortunato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bordoni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Bo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghezzi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagliarani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucchiari</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zecca</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamperti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronchi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguennouz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciscato</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Blasi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruggieri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroni</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turconi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toscano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients.</article-title>
                <source>Hum Mut</source>
                <volume>29</volume>
                <fpage>258</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">17994539</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.hackman.2002.492">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hackman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vihola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haravuori</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarparanta</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Seze</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labeit</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Witt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin.</article-title>
                <source>Am J Hum Genet</source>
                <volume>71</volume>
                <fpage>492</fpage>
                <lpage>500</lpage>
                <pub-id pub-id-type="pmid">12145747</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.hanisch.2007.157">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanisch</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimm</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xue</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traufeller</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merkenschlager</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zierz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deschauer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Frequency of calpain-3 c.550delA mutation in limb girdle muscular dystrophy type 2 and isolated hyperCKemia in German patients.</article-title>
                <source>Clin Neuropathol</source>
                <volume>26</volume>
                <fpage>157</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">17702496</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.haravuori.2001.869">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haravuori</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vihola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auranen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labeit</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene.</article-title>
                <source>Neurology</source>
                <volume>56</volume>
                <fpage>869</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">11294923</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.hashiguchi.2014.1097">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hashiguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adachi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arii</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kashiwagi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kagawa</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawai</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>A clinic-pathological investigation of two autopsy cases of calpainopathy (LGMD2A).</article-title>
                <source>Brain Nerve</source>
                <volume>66</volume>
                <fpage>1097</fpage>
                <lpage>102</lpage>
                <pub-id pub-id-type="pmid">25200581</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.hauerslev.2012.43">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hauerslev</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sveen</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krag</surname>
                    <given-names>TO</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Calpain 3 is important for muscle regeneration: evidence from patients with limb girdle muscular dystrophies.</article-title>
                <source>BMC Musculoskelet Disord</source>
                <volume>13</volume>
                <fpage>43</fpage>
                <pub-id pub-id-type="pmid">22443334</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.herasse.1999.4047">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Herasse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fougerousse</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockholm</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montarras</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinset</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorimachi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events.</article-title>
                <source>Mol Cell Biol</source>
                <volume>19</volume>
                <fpage>4047</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">10330145</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.hermanov_.2006.424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hermanov&#x000e1;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zapletalov&#x000e1;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedl&#x000e1;ckov&#x000e1;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chrob&#x000e1;kov&#x000e1;</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Letocha</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kroupov&#x000e1;</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000e1;mecn&#x000ed;k</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vondr&#x000e1;cek</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazanec</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mar&#x000ed;kov&#x000e1;</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voh&#x000e1;nka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fajkusov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients.</article-title>
                <source>Muscle Nerve</source>
                <volume>33</volume>
                <fpage>424</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">16372320</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.inashkina.2016.200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inashkina</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jankevics</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stavusis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasiljeva</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viksne</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Micule</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strautmanis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naudina</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cimbalistiene</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kucinskas</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krumina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Utkus</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burnyte</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matuleviciene</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lace</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Robust genotyping tool for autosomal recessive type of limb-girdle muscular dystrophies.</article-title>
                <source>BMC Musculoskelet Disord</source>
                <volume>17</volume>
                <fpage>200</fpage>
                <pub-id pub-id-type="pmid">27142102</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.jaka.2014.448">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jaka</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azpitarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paisan-Ruiz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zulaika</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casas-Fraile</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trevisiol</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krahn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Entire CAPN3 gene deletion in a patient with limb girdle muscular dystrophy type 2A.</article-title>
                <source>Muscle Nerve</source>
                <volume>50</volume>
                <fpage>448</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">24715573</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.joncourt.2003.667a">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Joncourt</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgunder</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallati</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>LGMD2A caused by a large deletion: clinical, histochemical and molecular analysis.</article-title>
                <source>Eur J Hum Genet</source>
                <year>2003</year>
                <volume>11</volume>
                <issue>S1</issue>
                <fpage>667A</fpage>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.kana.2014.278">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kellenberger</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Muscle magnetic resonance imaging of the lower limbs: valuable diagnostic tool in the investigation of childhood neuromuscular disorders.</article-title>
                <source>Neuropediatrics</source>
                <volume>45</volume>
                <fpage>278</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">25025777</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.kawabata.2003.623">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kawabata</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hata</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorimachi</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Newly identified exons encoding novel variants of p94/calpain-3 are expressed ubiquitously and overlap the alpha-glucosidase C gene.</article-title>
                <source>FEBS Lett</source>
                <volume>555</volume>
                <fpage>623</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">14675785</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.kawai.1998.1493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kawai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akaike</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunishige</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inui</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adachi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawajiri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishida</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kashiwagi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiwara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okuno</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roudaut</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyoshi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Clinical, pathological, and genetic features of limb-girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families.</article-title>
                <source>Muscle Nerve</source>
                <volume>21</volume>
                <fpage>1493</fpage>
                <lpage>501</lpage>
                <pub-id pub-id-type="pmid">9771675</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.keira.2007.513">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Keira</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurokawa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Characterization of lobulated fibers in limb girdle muscular dystrophy type 2A by gene expression profiling.</article-title>
                <source>Neurosci Res</source>
                <volume>57</volume>
                <fpage>513</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">17258832</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.keira.2003.659">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Keira</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle.</article-title>
                <source>J Biochem</source>
                <volume>133</volume>
                <fpage>659</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">12801918</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.khadilkar.2016.108">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khadilkar</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaudhari</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dastur</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaitonde</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yadav</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Limb-girdle muscular dystrophy in the Agarwals: utility of founder mutations in CAPN3 gene.</article-title>
                <source>Ann Indian Acad Neurol</source>
                <volume>19</volume>
                <fpage>108</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">27011640</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.kinbara.1998.415">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kinbara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorimachi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Skeletal muscle specific calpain, p94: structure and physiological function.</article-title>
                <source>Biochem Pharmacol</source>
                <volume>56</volume>
                <fpage>415</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">9763216</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.krahn.2006a.444">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krahn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pecheux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammouda</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobo</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leturcq</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2006a</year>
                <article-title>Screening of the CAPN3 gene in patients with possible LGMD2A.</article-title>
                <source>Clin Genet</source>
                <volume>69</volume>
                <fpage>444</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16650086</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.krahn.2011.398">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krahn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goicoechea</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanisch</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;cheux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Bragado</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leturcq</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeannet</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lobrinus</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacquemont</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strober</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000e9;vy</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Eosinophilic infiltration related to CAPN3 mutations: a pathophysiological component of primary calpainopathy?</article-title>
                <source>Clin Genet</source>
                <volume>80</volume>
                <fpage>398</fpage>
                <lpage>402</lpage>
                <pub-id pub-id-type="pmid">21204801</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.krahn.2006b.905">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krahn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Streichenberger</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pecheux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Testard</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pena-Segura</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoldi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poza</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouillot-Eimer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goicoechea</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Bragado</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leturcq</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2006b</year>
                <article-title>CAPN3 mutations in patients with idiopathic eosinophilic myositis.</article-title>
                <source>Ann Neurol</source>
                <volume>59</volume>
                <fpage>905</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">16607617</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.krahn.2007.582">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krahn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;cheux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e9;roud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouin-Garraud</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laforet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;nisson-Besnier</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leturcq</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000e9;vy</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Transcriptional explorations of CAPN3 identify novel splicing mutations, a large-sized genomic deletion and evidence for messenger RNA decay.</article-title>
                <source>Clin Genet</source>
                <volume>72</volume>
                <fpage>582</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">17979987</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.kramerova.2007.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kramerova</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spencer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A).</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1772</volume>
                <fpage>128</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">16934440</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.kramerova.2005.2125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kramerova</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kudryashova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkatraman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spencer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway.</article-title>
                <source>Hum Mol Genet</source>
                <volume>14</volume>
                <fpage>2125</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">15961411</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.kramerova.2008.3271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kramerova</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kudryashova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ottenheijm</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Granzier</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spencer</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle.</article-title>
                <source>Hum Mol Genet</source>
                <volume>17</volume>
                <fpage>3271</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">18676612</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.kuhn.2016.743">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kuhn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glaser</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joshi</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zierz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wenninger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deschauer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Utility of a next-generation sequencing-based gene panel investigation in German patients with genetically unclassified limb-girdle muscular dystrophy.</article-title>
                <source>J Neurol</source>
                <volume>263</volume>
                <fpage>743</fpage>
                <lpage>750</lpage>
                <pub-id pub-id-type="pmid">26886200</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.kyriakides.2010.767">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kyriakides</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacconi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siciliano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilton-Jones</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia.</article-title>
                <source>Eur J Neurol</source>
                <volume>17</volume>
                <fpage>767</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">20402744</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.lahoria.2016.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lahoria</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milone</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Rhabdomyolysis featuring muscular dystrophies.</article-title>
                <source>J Neurol Sci</source>
                <volume>361</volume>
                <fpage>29</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">26810512</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.leidenroth.2012.999">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leidenroth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorte</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilfillan</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ehrlich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyle</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hewitt</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Diagnosis by sequencing: correction of misdiagnosis from FSHD2 to LGMD2A by whole-exome analysis.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>20</volume>
                <fpage>999</fpage>
                <lpage>1003</lpage>
                <pub-id pub-id-type="pmid">22378277</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.lo.2008.34">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lo</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evesson</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seto</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choitis</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tay</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Compton</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cairns</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corbett</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacArthur</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>North</surname>
                    <given-names>KN</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Limb girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.</article-title>
                <source>Neuromusc Disord</source>
                <volume>18</volume>
                <fpage>34</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">17897828</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.luo.2011.402">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xi</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Clinical and pathological features in 15 Chinese patients with calpainopathy.</article-title>
                <source>Muscle Nerve</source>
                <volume>43</volume>
                <fpage>402</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21321956</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.luo.2012.723">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xi</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qiao</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Genetic variability and clinical spectrum of Chinese patients with limb girdle muscular dystrophy type 2A.</article-title>
                <source>Muscle Nerve</source>
                <volume>46</volume>
                <fpage>723</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22926650</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.magri.2017.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Magri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mongini</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mora</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroni</surname>
                    <given-names>I</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2017</year>
                <article-title>The Italian limb girdle muscular dystrophy registry: relative frequency, clinical fetaures, and differential diagnosis.</article-title>
                <source>Muscle Nerve</source>
                <volume>55</volume>
                <fpage>55</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">27184587</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.mahmood.2013.1907">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mahmood</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Q</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Limb-girdle muscular dystrophy subtypes: first reported cohort from northeastern China.</article-title>
                <source>Neural Regen Res</source>
                <volume>8</volume>
                <fpage>1907</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">25206500</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.matsubara.2007.819">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsubara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuchiya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pappolla</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A unique case of limb girdle muscular dystrophy type 2A carrying novel compound heterozygous mutations in the human CAPN3 gene.</article-title>
                <source>Eur J Neurol</source>
                <volume>14</volume>
                <fpage>819</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">17594342</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.mcdonald.1995.s117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abresch</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilmer</surname>
                    <given-names>DD</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Profiles of neuromuscular diseases. Limb-girdle syndromes.</article-title>
                <source>Am J Phys Med Rehabil</source>
                <volume>74</volume>
                <fpage>S117</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">7576419</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.mercuri.2005.164">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birchall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pane</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allsop</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fulizio</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures.</article-title>
                <source>Neuromusc Disord</source>
                <volume>15</volume>
                <fpage>164</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">15694138</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.meznaricpetrusa.2002.73a">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meznaric-Petrusa</surname>
                    <given-names>MMP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zidar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zupanic</surname>
                    <given-names>N</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Clinical, molecular and genetic features of calpainopathy in Slovenia.</article-title>
                <source>Neuromuscul Disord</source>
                <year>2002</year>
                <volume>12</volume>
                <fpage>73A</fpage>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.milic.2005.657">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milic</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canki-Klain</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Calpainopathy (LGMD2A) in Croatia: molecular and haplotype analysis.</article-title>
                <source>Croat Med J</source>
                <volume>46</volume>
                <fpage>657</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16100770</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.milic.2007.148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milic</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniele</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mora</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noulet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morandi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poupiot</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roudaut</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bittner</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A third of LGMD2A biopsies have normal calpain-3 proteolytic activity as determined by an in-vitro assay.</article-title>
                <source>Neuromusc Disord</source>
                <volume>17</volume>
                <fpage>148</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">17236769</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.minami.1999.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikezoe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mutations of calpain 3 gene in patients with sporadic limb girdle muscular dystrophy in Japan.</article-title>
                <source>J Neurol Sci</source>
                <volume>171</volume>
                <fpage>31</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10567047</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.monies.2016.32">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Monies</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alhindi</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almuhaizea</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abouelhoda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alazami</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goljan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alyounes</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaroudi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allssa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alabdulrahman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Subhani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Kalioby</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faquih</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakil</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altassan</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>BF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohlega</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>A first-line diagnostic assy for limb-girdle muscular dystrophy and other myopathies.</article-title>
                <source>Hum Genomics</source>
                <volume>10</volume>
                <fpage>32</fpage>
                <pub-id pub-id-type="pmid">27671536</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.moore.2006.995">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shilling</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westra</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wall</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wicklund</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stolle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michele</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccolo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winder</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stence</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barresi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florence</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fenichel</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stedman</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kissel</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griggs</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathews</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pestronk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serrano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darvish</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendell</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Limb-girdle muscular dystrophy in the United States.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>65</volume>
                <fpage>995</fpage>
                <lpage>1003</lpage>
                <pub-id pub-id-type="pmid">17021404</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.moriyoshimura.2017.465">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mori-Yoshimura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oya</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murata</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2017</year>
                <article-title>Cardiopulmonary dysfunction in patients with limb-girdle muscular dystrophy 2A.</article-title>
                <source>Muscle Nerve</source>
                <volume>55</volume>
                <fpage>465</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">27500519</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.narayanaswami.2014.1453">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Narayanaswami</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selcen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raynor</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wicklund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barohn</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ensrud</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griggs</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gronseth</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amato</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies. Report of the guideline development subcommittee of the American Academy of Neurology and the practical issues review panel of the American Association of Neuromuscular &#x00026; Electrodiagnostic Medicine.</article-title>
                <source>Neurology</source>
                <volume>83</volume>
                <fpage>1453</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">25313375</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.nascimbeni.2010.e1658">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasca</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Transcriptional and translational effects of intronic CAPN3 gene mutations.</article-title>
                <source>Hum Mutat</source>
                <volume>31</volume>
                <fpage>E1658</fpage>
                <lpage>69</lpage>
                <pub-id pub-id-type="pmid">20635405</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.nigro.2012.196">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piluso</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Next generation sequencing (NGS) strategies for the genetic testing of myopathies.</article-title>
                <source>Acta Myol</source>
                <volume>31</volume>
                <fpage>196</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">23620651</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.nigro.2014.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savarese</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Genetic basis of limb-girdle muscular dystrophies: the 2014 update.</article-title>
                <source>Acta Myol</source>
                <volume>33</volume>
                <fpage>1</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">24843229</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.norwood.2007.1305">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Norwood</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Visser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>EFNS guideline on diagnosis and management of limb girdle muscular dystrophies.</article-title>
                <source>Eur J Neurol</source>
                <volume>14</volume>
                <fpage>1305</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">18028188</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.norwood.2009.3175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Norwood</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eagle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population.</article-title>
                <source>Brain.</source>
                <year>2009</year>
                <volume>132</volume>
                <fpage>3175</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">19767415</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.oflazer.2009.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oflazer</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gundesli</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zorludemir</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabuncu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Din&#x000e7;er</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease?</article-title>
                <source>Neuromusc Disord</source>
                <volume>19</volume>
                <fpage>261</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">19285864</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.okere.2013.e12">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Okere</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reddy</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinnar</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>A cardiomyopathy in a patient with limb girdle muscular dystrophy type 2A.</article-title>
                <source>Circ Heart Fail</source>
                <volume>6</volume>
                <fpage>e12</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">23322878</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.ono.2010.22986">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ojima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torii</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takaya</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hata</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorimachi</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Skeletal muscle-specific calpain is an intracellular Na+-dependent protease.</article-title>
                <source>J Biol Chem</source>
                <volume>285</volume>
                <fpage>22986</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">20460380</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.ono.1998.17073">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimada</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorimachi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saido</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A.</article-title>
                <source>J Biol Chem</source>
                <volume>273</volume>
                <fpage>17073</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9642272</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.oygard.2011.20">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oygard</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haestad</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000f8;rgensen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Physiotherapy, based on the Bobath concept, may influence the gait pattern in persons with limb-girdle muscle dystrophy: a multiple case series study.</article-title>
                <source>Physiother Res Int</source>
                <volume>16</volume>
                <fpage>20</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">21110410</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.pantojamelendez.2017.e0170280">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pantoja-Melendez</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda-Duarte</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roque-Ramirez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zenteno</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2017</year>
                <article-title>Epidemiological and molecular characterization of a Mexican population isolate with high prevalence of limb-girdle muscular dystrophy type 2A due to a novel Calpain-3 mutation.</article-title>
                <source>PLoS One</source>
                <volume>12</volume>
                <issue>1</issue>
                <fpage>e0170280</fpage>
                <pub-id pub-id-type="pmid">28103310</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.pastorello.2012.230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pastorello</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trevisan</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Atypical onset in a series of 122 cases with facioscapulohumeral muscular dystrophy.</article-title>
                <source>Clin Neurol Neurosurg</source>
                <volume>114</volume>
                <fpage>230</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22079131</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.pathak.2010.549">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pathak</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarkar</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jha</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suri</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohd</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gulati</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Limb girdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation.</article-title>
                <source>Neurol India</source>
                <volume>58</volume>
                <fpage>549</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">20739790</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.p_nissonbesnier.1998.1078">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>P&#x000e9;nisson-Besnier</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Pseudometabolic expression and phenotypic variability of calpain deficiency in two siblings.</article-title>
                <source>Muscle Nerve</source>
                <volume>21</volume>
                <fpage>1078</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">9655129</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.perez.2010.502">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vital</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin-Negrier</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sole</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Diagnostic procedure of limb girdle muscular dystrophies 2A or calpainopathies: French cohort from a neuromuscular center (Bordeaux).</article-title>
                <source>Rev Neurol</source>
                <volume>166</volume>
                <fpage>502</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20044116</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.piluso.2011.1584">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Piluso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Vecchio Blanco</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aurino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savarese</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giugliano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terracciano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vainzof</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Criscuolo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casali</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Motor chip: a comparative genomic hybridization microarray for copy-number mutations in 245 neuromuscular disorders.</article-title>
                <source>Clin Chem</source>
                <volume>57</volume>
                <fpage>1584</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">21896784</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.piluso.2005.686">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Piluso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aurino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ventriglia</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belsito</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Totaro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saccone</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topalo&#x0011f;lu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimbeni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fulizio</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broccolini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canki-Klain</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>LI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes.</article-title>
                <source>J Med Genet</source>
                <volume>42</volume>
                <fpage>686</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">16141003</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.pogoda.2000.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pogoda</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krakhmaleva</surname>
                    <given-names>IN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipatova</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shakhovskaya</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shishkin</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Limborska</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>High incidence of 550delA mutation of CAPN3 in LGMD2 patients from Russia.</article-title>
                <source>Hum Mutat</source>
                <volume>15</volume>
                <fpage>295</fpage>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.pollitt.2001.287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pollitt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pogue</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davison</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach.</article-title>
                <source>Neuromusc Disord</source>
                <volume>11</volume>
                <fpage>287</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">11297944</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.prahm.2017.358">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Prahm</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feldt-Rasmussen</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2017</year>
                <article-title>Human growth hormone stabilizes walking and improves strength in a patient with dominantly inherited calpainopathy.</article-title>
                <source>Neuromusc Disord</source>
                <volume>27</volume>
                <fpage>358</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">28190647</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.quick.2015.661">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Quick</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waessnig</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schultheiss</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reuner</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichmann</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strasser</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speiser</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Evaluation of heart involvement in calpainopathy (LGMD2A) using cardiovascular magnetic resonance.</article-title>
                <source>Muscle Nerve</source>
                <volume>52</volume>
                <fpage>661</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">26032656</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.rajakumar.2013.2009">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rajakumar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexander</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oommen</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Oxidative stress, NF-kB and the ubiquitin proteasomal pathway in the pathology of calpainopathy.</article-title>
                <source>Neurochem Res</source>
                <volume>38</volume>
                <fpage>2009</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">23846623</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.reddy.2017.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reddy</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estrella</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valkanas</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsuhashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darras</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amato</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lidov</surname>
                    <given-names>HGW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brownstein</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margulies</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunkel</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacArthur</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>PB</given-names>
                  </name>
                </person-group>
                <year>2017</year>
                <article-title>The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States.</article-title>
                <source>J Hum Genet</source>
                <volume>62</volume>
                <fpage>243</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">27708273</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.restagno.1996.173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Restagno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagliano</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carbonara</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlini</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Prenatal diagnosis of limb girdle muscular dystrophy type 2A.</article-title>
                <source>Neuromusc Disord</source>
                <volume>6</volume>
                <fpage>173</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">8784805</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.richard.1995.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>How neutral are synonymous codon mutations?</article-title>
                <source>Nat Genet</source>
                <volume>10</volume>
                <fpage>259</fpage>
                <pub-id pub-id-type="pmid">7670461</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.richard.1997.1128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenguier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Din&#x000e7;er</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roudaut</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bady</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgunder</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chemaly</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halaby</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurnit</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefranc</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loiselet</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nivelon-Chevallier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ollagnon-Roman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Restagno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topalo&#x0011f;lu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins.</article-title>
                <source>Am J Hum Genet</source>
                <volume>60</volume>
                <fpage>1128</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">9150160</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.richard.1995.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broux</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allamand</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fougerousse</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiannilkulchai</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourg</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenguier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devaud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasturaud</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roudaut</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hillaire</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passos-Bueno</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zatz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischfield</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Mutations in the proteolytic enzyme calpain-3 cause limb girdle muscular dystrophy type 2A.</article-title>
                <source>Cell</source>
                <volume>81</volume>
                <fpage>27</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">7720071</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.richard.1999.1524">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roudaut</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pogue</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimbergen</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobo</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Diego</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ginjaar</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lasa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollitt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topalo&#x0011f;lu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Visser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Kooi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Calpainopathy-a survey of mutations and polymorphisms.</article-title>
                <source>Am J Hum Genet</source>
                <volume>64</volume>
                <fpage>1524</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">10330340</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.richard.2016.248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogrel</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockholm</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payan</surname>
                    <given-names>CAM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fougerousse</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Natural history of LGMD2A for delineating outcome measures in clinical trials.</article-title>
                <source>Ann Clin Transl Neurol</source>
                <volume>3</volume>
                <fpage>248</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">27081656</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.rosales.2013.731">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosales</surname>
                    <given-names>XQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malik</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sneh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kota</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gastier-Foster</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Astbury</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyatt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reshmi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodino-Klapac</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendell</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahenk</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Impaired regeneration in LGMD2A supported by increased PAX7-positive satellite cell content and muscle-specific microRNA dysregulation.</article-title>
                <source>Muscle Nerve</source>
                <volume>47</volume>
                <fpage>731</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23553538</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.sacconi.2012.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sacconi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Greef</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemmers</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salviati</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boileau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Maarel</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desnuelle</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Patients with a phenotype consistent with facio scapulo humeral muscular dystrophy display genetic and epigenetic heterogeneity.</article-title>
                <source>J Med Genet</source>
                <volume>49</volume>
                <fpage>41</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21984748</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.s_enz.2008.e3750">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azpitarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armananzas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leturcq</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alzualde</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inza</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Bragado</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De la Herran</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corcuera</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De La Torre</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Gene expression profiling in limb girdle muscular dystrophy 2A.</article-title>
                <source>PLoS One</source>
                <volume>3</volume>
                <fpage>e3750</fpage>
                <pub-id pub-id-type="pmid">19015733</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.s_enz.2005.732">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leturcq</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobo</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poza</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otaegui</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtasun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutierrez-Rivas</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emparanza</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paisan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goicoechea</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bl&#x000e1;zquez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnemann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figarella-Branger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti-Masso</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene.</article-title>
                <source>Brain</source>
                <volume>128</volume>
                <fpage>732</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">15689361</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.s_enz.2017.e7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2017</year>
                <article-title>Dominant LGMD2A: alternative diagnosis or hidden digenism?</article-title>
                <source>Brain</source>
                <volume>140</volume>
                <fpage>e7</fpage>
                <pub-id pub-id-type="pmid">27818383</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.salem.2012.92">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salem</surname>
                    <given-names>IH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsairi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mezghani</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kenoun</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Triki</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fakhfakh</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>CAPN3 mRNA processing alterations caused by splicing mutation associated with novel genomic rearrangement of Alu elements.</article-title>
                <source>J Hum Genet</source>
                <volume>57</volume>
                <fpage>92</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">22158424</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.savarese.2016.71">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Savarese</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Fruscio</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiorillo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruggiero</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Astrea</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passamano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruggieri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronchi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Amico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssens</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farina</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mutarelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marwah</surname>
                    <given-names>VS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garofalo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giugliano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanpaolo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Vecchio Blanco</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esposito</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piluso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Ambrosio</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petillo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musumeci</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodolico</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messina</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evil&#x000e4;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hackman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filosto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Iorio</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siciliano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mora</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maggi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacconi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santoro</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vercelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mongini</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gualandi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tupler</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Bleecker</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toscano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pegoraro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Politano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>The genetic basis of undiagnosed muscular dystrophies and myopathies.</article-title>
                <source>Neurology</source>
                <volume>87</volume>
                <fpage>71</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">27281536</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.schessl.2008.54">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schessl</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schreiber</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;nnemann</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korinthenberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Phenotypic variability in siblings with calpainopathy (LGMD2A).</article-title>
                <source>Acta Myol</source>
                <volume>27</volume>
                <fpage>54</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19364062</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.seong.2016.484">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seong</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seo</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seol</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>SI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chae</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Clinical application of next-generation sequencing-based gene panel in patients with muscular dystrophy: Korean experience.</article-title>
                <source>Clin Genet</source>
                <volume>89</volume>
                <fpage>484</fpage>
                <lpage>8</lpage>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.shaboodien.2015.152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shaboodien</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pillay</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heckmann</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayosi</surname>
                    <given-names>BM</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Limb girdle weakness in a marfanoid man: distinguishing calpainopathy from Becker&#x02019;s muscular dystrophy.</article-title>
                <source>Pract Neurol</source>
                <volume>15</volume>
                <fpage>152</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">25573340</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.shin.2007.463">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mutations of CAPN3 in Korean patients with limb girdle muscular dystrophy.</article-title>
                <source>J Korean Med Sci</source>
                <volume>22</volume>
                <fpage>463</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17596655</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.simeoni.2015.292">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Simeoni</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gigli</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scalise</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Facioscapulohumeral muscular dystrophy and limb-girdle muscular dystrophy: &#x0201c;Double trouble&#x0201d; overlapping syndrome?</article-title>
                <source>J Neurol Sci</source>
                <volume>348</volume>
                <fpage>292</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">25528007</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.sorimachi.2001.653">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sorimachi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The structure of calpain.</article-title>
                <source>J Biochem</source>
                <volume>129</volume>
                <fpage>653</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">11328585</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.stehl_kov_.2014.154">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stehl&#x000ed;kov&#x000e1;</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sk&#x000e1;lov&#x000e1;</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000ed;dkov&#x000e1;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mr&#x000e1;zov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vondr&#x000e1;&#x0010d;ek</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazanec</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voh&#x000e1;&#x00148;ka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haberlov&#x000e1;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermanov&#x000e1;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000e1;me&#x0010d;n&#x000ed;k</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sou&#x0010d;ek</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x00161;lej&#x00161;kov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dvo&#x00159;&#x000e1;&#x0010d;kov&#x000e1;</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sola&#x00159;ov&#x000e1;</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fajkusov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Autosomal recessive limb girdle muscular dystrophies in the Czech Republic.</article-title>
                <source>BMC Neurology</source>
                <volume>14</volume>
                <fpage>154</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">25135358</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.stramare.2010.585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stramare</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beltrame</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dal Borgo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallimberti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frigo</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pegoraro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubaltelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feltrin</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies.</article-title>
                <source>Radiol Med</source>
                <volume>115</volume>
                <fpage>585</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">20177980</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.straub.2012.s42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlier</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI.</article-title>
                <source>Neuromusc Disord</source>
                <volume>22</volume>
                <fpage>S42</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">22980768</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.sveen.2013.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sveen</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ingelsrud</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blichter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsen</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonck</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krag</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Resistance training in patients with limb girdle and Becker muscular dystrophies.</article-title>
                <source>Muscle Nerve</source>
                <volume>47</volume>
                <fpage>163</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23169433</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.talim.2001.692">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Talim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ognibene</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattioli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlini</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Normal calpain expression in genetically confirmed limb-girdle muscular dystrophy type 2A.</article-title>
                <source>Neurology</source>
                <volume>56</volume>
                <fpage>692</fpage>
                <lpage>3</lpage>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.ten_dam.2012.1716">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>ten Dam</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Kooi</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Wattingen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Haan</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Visser</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Reliability and accuracy of skeletal muscle imaging in limb girdle muscular dystrophies.</article-title>
                <source>Neurology</source>
                <volume>79</volume>
                <fpage>1716</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">23035061</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.thompson.2016.294">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Limb girdle muscular dystrophies - international collaborations for translational research.</article-title>
                <source>Nat Rev Neurol</source>
                <volume>12</volume>
                <fpage>294</fpage>
                <lpage>309</lpage>
                <pub-id pub-id-type="pmid">27033376</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.todorova.2007.225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Todorova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Georgieva</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Todorov</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bogdanova</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitev</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mueller</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremensky</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horst</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A large deletion and novel point mutations in the calpain 3 gene (CAPN3) in Bulgarian LGMD2A patients.</article-title>
                <source>Neurogenetics</source>
                <volume>8</volume>
                <fpage>225</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17318636</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.topalo_lu.1997.212">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Topalo&#x0011f;lu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Din&#x000e7;er</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ak&#x000e7;&#x000f6;ren</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alehan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozme</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ca&#x0011f;lar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karaduman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Calpain-3 deficiency causes a mild muscular dystrophy in childhood.</article-title>
                <source>Neuropediatrics</source>
                <volume>28</volume>
                <fpage>212</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9309711</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.urtasun.1998.1735">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Urtasun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;enz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roudaut</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poza</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobo</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia Bragado</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leturcq</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marti Masso</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain).</article-title>
                <source>Brain</source>
                <volume>121</volume>
                <fpage>1735</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">9762961</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.vainzof.2003.624">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vainzof</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Paula</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsanaclis</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zatz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A.</article-title>
                <source>J Clin Pathol</source>
                <volume>56</volume>
                <fpage>624</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12890817</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.van_der_kooi.1996.1471">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Kooi</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busch</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Haan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ginjaar</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Essen</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Hooff</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;weler</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jennekens</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jongen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oosterhuis</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Padberg</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spaans</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wintzen</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wokke</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Ommen</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolhuis</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Visser</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>The clinical spectrum of limb girdle muscular dystrophy. A survey in The Netherlands.</article-title>
                <source>Brain</source>
                <volume>119</volume>
                <fpage>1471</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">8931572</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.van_der_kooi.2007.2125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Kooi</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frankhuizen</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howeler</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Padberg</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spaans</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wintzen</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wokke</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Ommen</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Visser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ginjaar</surname>
                    <given-names>HB</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families.</article-title>
                <source>Neurology</source>
                <volume>68</volume>
                <fpage>2125</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17562833</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.vissing.2016.2154">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barresi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Witting</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Ghelue</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gammelgaard</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bindoff</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wahl</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnardottir</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahlbom</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonsrud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duno</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy.</article-title>
                <source>Brain</source>
                <volume>139</volume>
                <fpage>2154</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">27259757</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.wattjes.2010.2447">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wattjes</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kley</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Neuromuscular imaging in inherited muscle diseases.</article-title>
                <source>Eur Radiol</source>
                <volume>20</volume>
                <fpage>2447</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">20422195</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.young.1992.1370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foroud</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conneally</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischfield</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodes</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Confirmation of linkage of limb-girdle muscular dystrophy, type 2, to chromosome 15.</article-title>
                <source>Genomics</source>
                <volume>13</volume>
                <fpage>1370</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">1505977</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.zatz.2003.532">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zatz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Paula</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starling</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vainzof</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The 10 autosomal recessive limb-girdle muscular dystrophies.</article-title>
                <source>Neuromusc Disord</source>
                <volume>13</volume>
                <fpage>532</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">12921790</pub-id>
              </element-citation>
            </ref>
            <ref id="lgmd2a.REF.zatz.2000.511">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zatz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vainzof</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passos-Bueno</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes.</article-title>
                <source>Curr Opin Neurol</source>
                <volume>13</volume>
                <fpage>511</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11073356</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="lgmd2a.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="lgmd2a.Suggested_Reading.reflist0">
            <ref id="lgmd2a.REF.kang">
              <mixed-citation publication-type="book">Kang PB, Kunkel LM. The muscular dystrophies. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G., eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> Chap 216. New York, NY: McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="lgmd2a.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="lgmd2a.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>3 August 2017 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>5 July 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>8 July 2010 (cd) Revision: deletion/duplication analysis available clinically</p>
            </list-item>
            <list-item>
              <p>3 December 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>15 December 2005 (ca) Revision: prenatal diagnosis available</p>
            </list-item>
            <list-item>
              <p>10 May 2005 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>29 November 2004 (ca) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
